Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Bacteroides fragilis NCTC 9343, ATCC 25285 = NCTC 9343

>BF1439 putative ABC transporter permease component
MIKQYFKQSLVLLQQNKLLSVIAIIGTALAIAMIMCIVLIYQARTANYEP
EINRDRTLSIEMTIAQKIDDKGWNMGNQLSLRTIKECFYPMTTAEAVSAV
HYSMTSLAATPDGTREGKCAVSYTDDNFWRVFGFRFLHGKPYGQEFVSGE
KKLVVTRSLARRLFGIDNAVGRIISLGFVDYTVCGVVADVSVLAEAAYAE
AWAPYTALPDYERSVSEGLQGGYSCYILVPKGADPDVVRAEAQQNVDRMN
ANQKELKLLLGGAPDTRLMSLARDNPFDDPDTSRLVLIYIVVITILLLVP
AINLSGITLSRMRRRMEEIGVRRAFGATRGELLRQVLAENLVVTLMGGVL
GLILSYIAVLCMRDWLLNTSMSGYYGVDTQVSAGMVIQPFVFVCALLFCL
LMNLLSAGIPAIRVSRTNIVNAIK
>BF2650 putative BAC transport system, two-fused ATP-binding domains protein
MKPAVSVNDVTKRYGEVEALKSATFSVNPGELFGIIGPDGAGKSTLFRIL
TTLLLADSGTATVNGLDVVKDYKQIRQQVGYMPGRFSLYQDLTVEENLDF
FATVFHTTIRENYDLVKDIYQQIEPFRKRRAGALSGGMKQKLALSCALIH
KPEILFLDEPTTGVDPVSRKEFWEMLRHLKDQGITILVSTPIMDEARQCD
RIAFINEGEIQGIDVPERILQRFSHILCPPGLERTEVHAGNDFAIEVDQL
TKCFGHFTAVDHISFRVNRGEIFGFLGANGAGKTTAMRMLCGLSKPTSGM
ARVAGFDVAAHPEEVKKNIGYMSQKFSLYEDLKVWENIRLFAGIYGMQDR
EIAEKTDALLDRLGFSGERDTLVKSLPLGWKQKLAFSVSIFHNPRIVFLD
EPTGGVDPATRRQFWELIYQAADRGITVFVTTHYMDEAEYCNRVSIMVDG
RIEVLDTPRGLKAHFHADTMDDVFQQLARKAVRKAD
>BF1882 putative transmembrane transport efflux protein
MTHRIQQESIKRRLAKLAAPIFIETLLIMMLGAVDTIMLSRHSDNSVAAV
GVVNQIIMLTFLVFEVINLGTSVLCSQYLGARLEKKVVQVVGVSLLVNLL
VGGIISLILFTMARTILQWMGLGPELMADGMDYMRIVGAFAFFQAISLTL
SASLRSANKAIYPMLVTVVVNILNIIGNYSLIFGKFGCPELGVEGAAIST
AFSRGVSMVILFVILFRKHIHRFPLAYFRPFPFIELKNLMRVGLPSAGEQ
LSYSSSQVVITFFINMLGVEALATRTYCVNIIMFVYLFSISMAQGGAICI
GHLIGEKKPHAAFLLGKYVMKKSVMITLILSGIIAASGHAILSWLTSNPE
IIRMGVIVLLIDVVLEIGRPINIFATNALRAAGDVNYPFYVGLVVMWSVA
VGIGYLFGIYWAWGICGMWVAFALDENIRGIIFVRRWYGMKWVNKSFVRS
>BF4140 putative muramoyltetrapeptide carboxypeptidase
MNLQFPPFLHEGDKVAIVSPSSKIDSIFLKGAKTRLSSWGLTPVMGDHVR
SSWGSYAGATHQRLKDFQAAMDDEEIKAILCSRGGYGAVHLLDKLDFTRF
RNHPKWLIGFSDITALHNLFQYNGFASLHAPMARHLAVTGEEDPCSLYLR
DILFGKLPGYKCHRHKLNHLGQAKGILRGGNMAVFHGLRGTPYDIPPEGT
ILFIEDVGERPYAIERMMYNLKLGGVLEKLSGLIIGQFTEYKEDYSLKKD
LYSTLDALVKEYDFPICYDFPVGHVTENLPLINGAEVEFVSGKKGVELLI
NPPI
>BF1960 putative MatE-family transmembrane protein
MQGIKNLTQGPINKQLFNLAMPIMATSFIQMAYSLTDMAWVGRLGSEAVA
AVGSVGILTWMSGSISLLNKVGSEVSVGQSIGAQNHEDARNFASHNITIA
LIISLCWGGLLFLLARPIIGIYELEAHITENAIAYLRIISTGLPFIFLSA
AFTGIYNAAGRSKIPFYISGTGLVLNILLDPLFIFGFGLGTNGAAYATWI
SQAAVFGIFIYQLRCRDALLGRFSFFTRLKKKYTHRILKLGLPVATLNTL
FAFVNMFLCRTASEQGGHIGLMTFTTGGQIEAITWNTSQGFSTALSAFIA
QNYAAGRTDRVIKSWHTTLLMTSIFGTLCTLLFVFFGNEIFALFVPEQAA
YEAGGVFLRIDGYSQLFMMLEITTQGVFYGIGRTIPPAIISITCNYMRIP
LAILFVRMGMGVEGIWWAVCVTTVAKGLILAGWFALIKRKVLSRPIL
>BF3288 hypothetical protein
MCGLSKKKMPYLYLIDEAIGLLNNEIRLVEWRIKYPEQFKPHFNKQPFSP
LYLADKTNLIDIMEIISSLFLSKHIVYKNGKPAFLSDFSKAFEWVFNIQL
KDYHQKHEDVIKRKLGKITEFLNGLSDLIRNEHDKKGYR
>BF2984 putative ABC transport system, membrane protein
MLTNIETMDNPSKIKTQTKASSFTLIVAFICVALIGLALIPLLPVKLNPS
RTLPGFTVQFSMPGTSSRVVEIEATSKLEAMLARIKGIKNIYSTSDNGSG
SITIELDKYADIDAVRFEASTIIRQTWPQLPDGVSYPYIRMKRPDENASR
PFMSFTLNAPSTPILIQQYADEHIKTRLAQIQGIYKIDLSGATPMEWVLE
YDSEQLRRLGITLSDIQQAVSRYYLKEFLGTYNVESSTGGKEWIRLALMP
ETKDEGFDASRIRVKSAEGKLISLDELVTVSHMEEAPQSYYRINGLNSIY
LSITAEETANQLQLSKQVKEEMEAIQKVLPAGYEIHTSYDATEFIHEELN
KIYLRTGLTVLILLFFVLIITLNPRYLFLIVVSLSINIAVAVIFYYLFGL
EMQLYSLAGITVSLNLVIDNTIVMTDHILHRRNLKAFMSILAATLTTMGA
LVIIFFLDEKIRLNLQDFAAVVIINLAVSLFVALFFVPALIEKIGLKKRK
RRRTQSRFFLLRASLPRRITVYFTRFYGWMIRKLCRWRVAVCILLILLFG
LPVFMLPDKVEGEGRATEWYNKTLGSSTYKEKIKPIVDKALGGSLRLFIQ
KVYNGSYFTRNEEVVLYVYANLPNGSTLEQMNELIKKMEIYLSQFKEIKQ
FQTSVYNARRGNINIYFTKEHQNSGFPYTLKANIISKALQLGGGSWGVYG
LQDQGFSNDVREGAGSFQVKMYGYNYDELYEWAEKLKAKLLTHRRIKEVI
INSYFSYWKDDYQEFYFNLNRERMAQENINANILFSTIRPIYGKNMEIGS
VVAENGSEKIKLSSKQSQEYDIWAMQYFPYGTDDKQYKLSELATMEKGQM
PQQVAKENQQYRLCLQYEYIGSGEQGNKILKRDLEEFNKELPMGYTAQSE
RESWGWGKKDNKQYLLLLVVIAIIFFTTSILFNSLKQPLAIIFIIPVSYI
GVFLTFYWFKLNFDQGGFASFVLLCGITVNASIYILNEYNAIRRRHPRMS
ALRAYTKAWNAKILPIFLTVVSTILGFIPFMVGTDKEAFWFPLAAGTIGG
LVMSIIGIFFFLPVFVLKKRVGKR
>BF2215 putative ABC transport system, membrane protein
MKQFHYTIQTLIRDRRSCVIKVISLSLGLLVSIILFSRVAFELSYDNCFQ
DVDNLYIVKTEWIKDGVIKGNAGSYTLIPIASTVAEEFPKEVESAVCSSI
SFEAIFKIGNRKMNKSFILSDSLYFRTMGIEVISGNPNDLTNPDVLFLSQ
SVAREAFGEENPIGKTLHMMVWGTPVEALVKGVFADLPYNVSLERHEAVL
SFASHSKYGWGRPGWTSGGNYNAFIRLKDGERSADVINTDIDKVIAKHIP
SDMNMHLHMFVVPLRTIHLEHSDVKRTILILSLLGFAILFAATMNYVLIF
VSSLSQRAKGIGIHKCNGASDKAIFSMFIYETALIIGVSLVLMIIFLFQF
QEKIEELAEVSLSSLFTWHNLWAPLSVVTFLFVIGGILPGKIFSLIPVTQ
VFHPYIKENRGWKRILLFIEFAGVAFIFGLMCVAYLQCHYIINRDMGYQP
KGVASCKHDFAEPDNARNNLKSLPYVEGVASIRGSMTWFGNREVTDEGGK
VLFTPRCAAFDKDFVPLLGLHIKTGRNFTGERQFLVNQPYVEKMGWKGSG
VGEIVPNRGTVVGVLAPFCCGVLPADNEPLEIEYGTNLRNVHVRLKEPFT
ENLHRLNNEMKKIYPQEDIEFRSLEQDLERYYRPTIIFRDATFLAFITIL
FITLMGLIGYINDEVRRRSKEIAIRKINGAEARSILFLLSKDIFWVAILS
VAIGTYGAYYMSLLWISQFEDTICVYAGWYVVTAICLLVFIFVFIIGRSW
HIANENPVNSIKSE
>BF0510 putative ABC transporter
MIDIWQEIYGTIKRNKLRTLLTGFAVAWGIFMLIVLLGAGNGLIHAFEKS
SSARALNSIKIYPGWTGKPYDGLKEGRRIQLDNKDLDATMEHFSDNIISV
GASQWQSNVNLSYGQEYVNLSLEGVYPNFTEVESVKSTDGRFINDIDLKE
RRKVIVLHTKTAEILFGKSKTEPIGKFVNAGGVSYQVVGLYTDPGDQGSS
EAYIPFSTLQVIYNKGDKLNNLTFTTKGLTTIETNEAFEAAYRKVMGAKH
RFDPSDNSALWIWNRFTNYLQSQNAMGILRTAIWVIGIFTLLSGIVGVSN
IMLITVKERTREFGIRKALGAKPFSILWLIIVESVTITTLFGYIGMVAGI
AATEWMNKVAGEQTVDVGMFSETVFLNPTVDISIAIQATLTLVVAGTLAG
FFPAKKAVSIRPIEALRAD
>BF3852 putative transport related membrane protein
MNIIRGALRRPISTLVLVFGLLFFGIKAVRDIRVDILPDMNLPVVYIAHA
FNGYTPEQMEGYFTKMYTNMMLFTNGIKNIETKNSQGLTLMKVTFYPDTD
MGQAIAELSALSNRSQIFLPPGTPDPFIIRFDASSQPVGQVVFRSPTKNN
NQLQDIANFTARPFLISVPGITTAPPFGGSPRTIEINVDPQALRAHKLAP
EQIVEAISRNNITAPSGNIFTEDKNYITPTNNNLKTVREFEDIPLVKGSV
GTVFLRDVATISDGADIATGYALVNGKRSVYINVAKSGNASTWDVVKNLK
KRLPVIQNNLPDDVTVSFEFDQSVYVINAVKNLLTEGFIGVILTGLMVLL
FLRDRRSAFIVILTIPISLISGVLFLHLFGQSINIMSLSGLALAVGILVD
ESTVTIENIHRHLELGKPKAVAVWEACREIAFPKFLILLCVLAVFVPAFL
MNGIPGAMFRPLAMAIGFSMITSFILSQTFVPVMASWIIRPNHAISTNGH
NESGSNKLLERQLERLLKRRKQIVSTYIVGVVAIVILLFGIIGTDVLPKG
NPSQFQVRLVAPQGTRIEITEDKVREFMGELETLIGEKHIRISSAFVGQH
SSTFAVSPVYIYNSGPHEATLQVALQDWHGDMEHLKEQLRCRINESMPEM
SITFEPMELSEKVLSQGANTPIEVRFSGMMKKQNEAYARKLLGKLKEIDY
LRDQKMPQSMNYPTYNIEVDRIRASQIGMDMADISGSLVPSTSSSRFTNK
NFWIGGMMNMAYNVQVQIPLNKMSSKEELEALPLSRKAPGKVLGDVANIT
EGTTYGETYNEGSMSYTTVVANIHDVDLGTALKDVRNAIASLGELPKGLN
VEVTGLASVLEETQRGLQEGLLIAVIVILLLLTANFQSFKVALVVITSVP
AVIMGALTLLWITGSTLNLQSYMGIIMSVGVSISNALLLVTAAETIRKTS
GNSLQAALQATSLRLRPILMTSIATLVGMLPMAIGFGEGGAQTAPLGRAV
IGGILASTLIGLFVLPLAFAWVQEKSSTLSVSLDPEDHNSKYYQEKK
>BF1610 putative ABC transport system ATP-binding protein
MIKTEKLSMLFTTEEVQTKALNEVTMQVERGEFVAIMGPSGCGKSTLLNI
LGTLDSPTSGSYFFEGKQVDKMNENQLTALRKGNLGFIFQSFNLIDELTV
YENVELPLVYLGMKPAIRKEKVKQVLEKVNLLHRANHFPQQLSGGQQQRV
AIARAVVTDCKLLLADEPTGNLDSVNGVEVMELLRELNRQGTTIIIVTHS
QRDATYAHRIIRLLDGKIVAENINRPLDETSGTNTESV
>BF2986 putative ABC transport system, membrane protein
MIKFLIQRPIAVLMAFTACFIVGLVTYFTLPVSLLPDISIPEITVQVSAK
NTSARELENTVVKPVRQQLIQVAALKDMTSETRDGAGIIRLSFDFGTNTD
LAFIEVNEKIDAAMNYLPKDTDRPKVIKASATDIPVFYLNLTLKTDSAYE
ETDQQAFLNLCEFSESVIKRRIEQLPEVAMVDVTGLLERQLQIVPDMDKL
AMLELSIEDIETALAQNNVEPGSMTVRDGYYEYNIKFSTLLRTAEDVENI
YIRKGDRIIQLKEFCRIAIVPVKEKGVSVSNGKRAVTLAIIKQADENMDN
MKDALSETMDYFKKIYPDIEFSVSRNQTELLDYTISNLQQNLSLGFVFIC
IVAVLFLGDVKSPFIIGLSMVVSIVISFLFFYLCKMSLNIISLSGLILAL
GMMIDSSIIVTENISQYREKGYSLRRACVAGTSEVVTPMLSSSFTTIAVF
VPLVFMSGIAGAIFYDQAFAVTVGLMVSYFTGIMLLPVLYMLVYRTGIKG
GPKWLRLKINNPLKEHTLDRFYDKGVDWVFSHKTLSVLFCAISFPLCIFF
FYFIDKERMPDIDENELITRIEWNENIHVDENQRRVDELFRELQGASVEQ
TASIGLQDYILNREQELSSSEAELYFKTETSKEIAPLQEQIYQKLKERYP
LAVISFSPPETVFEKLFVTGEADIVAELYARNKDRAPGPGTLRGLEQTFG
QKTGIPPTGIAFENQLNLSINQEKLLLYQISYNELYRVLRTAFKENSVAM
LHSYQQYLPISIAGDEKTVNQVLQETLIQTQPDSKTGEVNFIPLRELIKV
TPAEDLKSITAGRNGEYIPYKFYGVENAEKLMTQVKETSSETGDWDIAFS
GSFFSNQKMLDELVVILFISLLLMYFILAAQFESFMQPLLVLMEIPIDVA
FALVLLWVCGHTLNLMSAIGLIVTCGIVINDSILKLDAINELRKEGVPLL
EAIHEAGRRRLRPIIMTSLTTIFAMVPLLFSFDLGSELQKPLSIAMIGTM
TIGTLVSLFIIPLLYWFIYRNKEKR
>BF1537 putative type I restriction-modification specificity protein
MNSYYEKIIATGEVKCIDEEIPFEIPKGWEWCRLRQITSLLGDGIHGTPE
YDPNGEYYFVNGNNLQDKKIVIKPDTKKVSREEYLKYKKNLNKHTVLVSI
NGTLGNIGFYNDEPIMLGKSACYFNLIVEDLKEYVYILLQSPFFMEYTLK
AATGTTIKNVSLMAMNNLLIPLPPLCEQNRIVDRMTILDTKVKQYQKQET
CLRELNNNIYSILKKSILQDAIQGKLVPQIAEEGTAEELLAEIHKEKERL
VKEGKLKKSALTDSIIFKGDDNKYYERIGGKDICIDDEILFEIPDSWVWC
RLGFLFNHNTGKALNASNKEGSMLPYITTSNLYWGQFDLSSVRQMYFKDS
EIEKCSVSNGDLLVCEGGDIGRAAIWPYDTPMCIQNHIHKLRSYNQLDTL
FYYYIFQAYKYNGYIGGKGIGIQGLSSKALHNMLVPLPPINEQIRITSKI
SSLFQFI
>BF3151 putative AcrB/AcrD/AcrF family membrane protein
MNLAKYSLDNTKVIYFFLAVLLIGGVFSFGKLGKKEDAPFVIKSAVIMTR
YPGAEPAEVERLITEPISREIQSMSGVYKIKSESMYGISKITFELLPSLP
ASSIPQKWDELRRKVLNIQPQLPSGSSVPTVSDDFGDVFGIYYGLTADDG
FSYEEMRNWAERIKTQVVTADGVMKVALFGTQTEVVNISISVNKLAGMGI
DPKQLAGLLQSQNQIINTGEITAGEQQLRVVANGMYTTVDDIRNQVITTR
AGQVKLGDIAVIEKGYMDPPSTIMRVNGKRAIGIGVSTDPQRDVVLTGEM
VDKKLAELLPLMPVGLNLESLYLENVIAKEANNGFIINLIESILIVIVII
MLVMGMRAGVLIGTSLVFSIGGTLLIMSFMGVGLNRTSLAGFIIAMGMLV
DNAIVVTDNAQIAIARGVDRRKALIDGATGPQWGLLGATFIAICSFLPLY
LAPSSVAEIVKPLFVVLAISLGLSWVLALTQTTVFGNFILKSKAKNAGKD
PYDKPFYHKFEKILSVLIRRKIVTLGSMIVLFVVSLVVMGMMPQNFFPSL
DKPYFRADVFYPDGYGVNDVAREMKKVEAHLLKLPEVKKVSITFGSTPLR
YYLASTSVGPKPNFANVLVELNDSKYTKEYEEKFDVYMKANFPNAITRTS
LFKLSPAVDAAIEIGFIGPNVDTLVALTNQALEIMHRNPDLINIRNSWGN
KIPIWKPIYSPERAQPLGVSRQGMAQSIQIGTNGMTLGEFRQGDQVLPIL
LKGNSVADSFRINDLRTLPVFGNGPETTSLEQVVSEFDFRYRFSNVKDYN
RQLVMMAQCDPRRGVNAIAAFNQIWSQVQKEIKIPEGYTLKYFGEQESQV
ESNEALAKNLPLTFFLMFTTLLLLFKTYRKPTVILLMLPLIFIGIVLGLL
LLGKSFDFFAILGLLGLIGMNIKNAIVLVDQIDIENQSGLDPRKAVIKAT
ISRIVPVAMASGTTILGMLPLLFDAMFGGMAATIMGGLLVASALTLFVLP
VAYCAIHRIKG
>BF3812 putative hemolysin secretion transport system ATP-binding protein
MKLNSFPHYLQLDAMDCGPSCLRMIAKYYGKSYSLQTLRARSFITREGVS
MLGISDAAESIGFRTSGVRISLEQLKKDVPLPCILHWNQNHFVVCYDIKK
KRSGYRFYIADPARQLISYSEEEFKKCWLSTKVNGEEKGAALALEPGPEF
QGQGDEEESGSRSLRFFLKYLSPYRKQLIQLILGMLTASLLQLIFPFLTQ
SLVDVGIRDGNLNFITLILISQLVISVSQLSVEFIRSWIMLHMNTRINIS
LISDFLAKLMKLPLHYFDTKMIGDIMQRIGDHGRIESFLTGSSISTLFSF
VNFFIFAFVLAYYNLGILAIFLVGNSLYICWILVFMKYRRELDIRRFAQA
AGEQSSLIQLVTAMQEIKLNNCEKQKRWQWERIQVKLFKISVKGLALGQV
QQVGSVFFNQTTNIVISFIAAKSVVEGNMTLGMMMSLTYIIGQLSGPIGS
FIGFAQQLQDAKISLERLNEIHGQKDEEQDIASKLTVLPERRDIRIENLS
FSYDGADRDYVLNDVNLNIPEHKVTAIVGASGSGKTTLIKLMLGFYTPNK
GDIKIGETPLDVVNPHLWRAKSGSVMQDGFIFSDTIANNIAVGEEQVDVE
RLRHAVTVANIRDFIDSLPLGYNTKIGMEGNGISQGQRQRLLIARAVYKN
PEFLFFDEATNALDANNEREIMEHLHTFYRGKTVVVVAHRLSTVRDADKI
VVLDRGAVAEEGTHRELTEKKGLYYQLVKNQLELGS
>BF2214 putative ABC transport system, membrane protein
MKQLYYTIQTLLRGRGSNVIKVISLTLGLLVGILLFARVAFELNYDSYYS
EPENLCITLRTGISDGIKKEPNIDNYGKLAEAIRENFPDEVEDATVLDLF
SQSPLYHEGKKMEHVILATSKSHVFSTLGIKVLLGDVSQLDRVDVIFISR
SLARRLFADANPIGKTINIEIDYPLTVQGVFEDIPENTEFHFDGVYSFDT
RSKQYGSERGGWGYDSSYHCMVRFRHPDEREKVEVRMPEMLKKYIHNYKG
QSEEYSFMTPSQYHLQKPESRKIVMILSILGFAILLVAGMNNVLISVSSL
AQRAKSVGIHKCNGASDGHIYRMFLYESALLILLSLLFVTVLLFTFKLEI
EDLSGASLKALFTWQTLWVPILVSLVLFLVIGLFPGKLFAAIPVTQVFHR
FTAHRFVWKRSLLFIQFAGIAFILGLLMVILLQYHQVMTRDMGYKVDNLA
VGWSPYREIDKMDGILRGLPIVEEFCNASTIIYGGYMGQPYTDAHGKEFM
GRIEFVDEHYVPVMGLQIIKGRNIQQDKEILINEEMVRQIGWTDSPIGKN
LEDGKNNFGTIVGVVKDYVVQSAYMPQAPVALMSNLEWMNVLNKRNIILK
EPFGENLAKINTLMKEAFPTVDIVFRSARQEIDKQYQEVRRFRNVVIIAS
IAILLIALMGLFGFVNDEIQRRSKEIAIRKVNGAEVPDILRLVSGNIFWT
ALSAVLVGIVFAYIVSNKWLEQFSDRVSVNGGHFLVVIIIILLLIIGSVI
GRSWNVANENPVNSIKNE
>BF1457 putative type I restriction enzyme
MSAVTNHKQLIVMEVNKKKLKEQEIRTLLITPALQQKGWAVSINMREEYY
FTDGRVLVVGNQHSVAEGKKADYLLYHNGKPIAVVEAKDNKHTVGSGMQQ
AMDYALILDLKFAYSSNGDAFLEHDFITGKETEIKLEDFPTEEELYNRYL
ASKNYTPDELNIIETPFYYDAHSHEPRYYQRIAVDRTVEAIAKGQQRVLV
VMATGTGKTFTAFQIIHRLHKSGAKKKILYLADRNILIDQTMTQDFKPFK
KFMTKITSVGEGEEKIDSSYEMYMALYHQLVGKEGRPDPFLEVRPNFFDL
IIVDECHRGSAKDDSAWRKVLEYFNTATQIGMTATPKADEGANNLDYFGE
PVYTYSLLQGINDGFLAPYRVTADFINVDLQGWTPEEGEIDLLGKEIEQK
LYQRQNIGRDLAIKLRRKVVANRITKMLHDIGRMTKTIVFCSDIEEAAEM
RTLLINMNSDLCKKSPYYVTRIVGEDKEGKKQLDNFISVDEPYPVIVTTS
ELLSTGVDCKTCGLIVIDKEIGSMTEFKQIIGRGTRLRKDKGKWHLEILD
FRNATAKFKDPTFDGDPEPPKGGGKKPKPYKIIDGPSTVVSEPHEKYIIN
GKDIRIAHEIVSVLGEDGKTMRTESIQSFARTQLLRHYQSLNDFIQTWTE
AERKQAIMDELKEYAILIDAVREANPALKDADIFDVICHVAFDQPPLTRK
ERANNVKKCNYFGKYEGKAREVLEALLEKYAENGILDFEKANILEIPPFN
SIGKPTKIIKLFGGIAGYEQAIRELEYQIYKLA
>BF2531 putative membrane protein
MKTSGKLSQISFIIAREFRAISTSYAVLLVLMGGIFVYGLLYNYMYAPNI
VTDAPVAVVDNSHSSLSRQYIRWLDATPQVAVYAQAMDYREAREWMKEGK
VQGILYIPHDFETRVFQGREAVFSLYATTDAFLYFEALQEATSRVYLAIN
DAHRMDGAVFLPPQGLLAVAMAKPVNVAGTALYNHTEGYGSYLIPAVMMV
IIFQTLLMVIGMLTGDEYQHRATEPLLPGGRTADKSGLWGGAMRLVAGKT
FVYCGLYTVFSMFLLGLLPHFFSIPNIGNGLYITAMMVPYLMATSFFGLA
ASRYFTDSEAPLLMIAFFSVGLIFLSGVSYPLELMPWYWRMAHYILPAAP
ATLAFVKLNSMGADMADIQPEYITLWIQVIVYFGLSVWVYKKKLEA
>BF0607 putative AcrB/AcrD/AcrF family efflux transporter
MNISELSIRRPVLSTVLTIIILLFGLIGYNYLGVREYPSVDNPIISVSCS
YPGANADVIENQITEPLEQNINGIPGIRSLSSVSQQGQSRITVEFELSVD
LETAANDVRDKVSRAQRYLPRDCDPPTVSKADADATPILMVALQSDKRSL
LELSEIADLTVKEQLQTISDVSSVSIWGEKRYSMRLWLDPIKMSGYGITP
IDVKNAVDKENVELPSGSIEGNTTELTIRTLGLMHTAEEFNNLIVKEEND
RIIRFSDIGRAELGPADIKSYMKMNGVPMVGIVVIPQPGANHIKIADAVY
ERMEKMQKDLPEDVKYSYGFDNTKFIRASISEVKETVYVAFILVIIIIFL
FLRDWRVTLVPCIVIPVSLIGAFFVMYLADFSINVLSMLAVVLAVGLVVD
DAIVMTENIYVRIEKGMPPKEAGIEGAKEIFFAVISTTITLVAVFFPIVF
MEGMTGRLFREFSIVISGSVIISSFAALTFTPMLATKLLVKREKQNWFYL
KTEPFFEGMNRLYSRSLAVFLHKRWIALPFVAITIGIIAFLWNYIPAEMA
PLEDRSQISINTRGAEGVTYEYIRDYTEDINDLVDSIVPDAESVTARVSS
GSGNVRITLKDMKDRDYTQMDVAEKLSAAVQKKTMARSFVQQSSSFGGRR
GGMPVQYVLQATNIEKLQEVLPKFMAKVYENPVFQMADVDLKFSKPEARI
NINRDKASIMGVSTRNIAQTLQYGLSGQRMGYFYMNGKQYEILGEINRQQ
RNTPANLKSIYIRSDKGDMVQLDNLIELTGGIAPPKLYRYNRFVSATVSA
GLAEGKTIGQGLDEMDKIAKETLDDTFRTALTGDSKEYRESSSSLMFAFI
LAIVLIYLILAAQFESFKDPLIIMLTVPLAIAGALVFMYFGGITMNIFSQ
IGIIMLIGLVAKNGILIVEFANLKQETGEDKMTAIKDAALQRLRPILMTS
ASTILGLIPLAFASGEGCNQRIAMGTAVVGGMLVSTLLTMYIVPAIYSYI
STNRSNKLKQE
>BF3761 putative conserved transport-related membrane protein
MKEREKKYIALWLVMKRECHRLVSRPLYLFCMVIAPLFCYIFFTTLMDSG
LPTNMPVGAVDLDNSASSRNILRNLDAFGQTAVVARYSSVNEARTAMQEG
KIYGFFYIPKGMSADAQSQRQPKLSFYTNNSYLIAGSLLFKDMKMMSELA
SGAAARSVLYAKGATEDQAMGYLQPIVIDTHPIQNPWLNYSVYLCNTLVP
GVLMLLIFMVTVFSIGVEIKDRTAREWLRLSNNSIYIALAGKLLPQTVVF
FIMGIFYNVYLYGYLHFPCNSGILPMLLATLCLVLASQCCGILMIGTLPT
LRLGLSFASLWGVISFSISGFSFPVMAMNPVLQALSNLFPLRHYFLIYVD
QALNGYSMAYSWSNYMALLIFMLLPFFVVHRLKEALIYYKYVP
>BF0610 putative ATP-binding transporter component
MRINFPSYIQHDQMDCGPACLKIIAQNYGKRFSLKYLRDRCYATREGVSL
FDIGRAAEEIGFRTLAIKVTFEDLIEKMPLPLIVHWKQSHFVVVHKITNR
KVYISDPAQGLTHYNHKEFREAWEMCNGLGTIMILETTPEFHNMNEMETR
ASFSHFMKYLKPHHRYLGQVIVGMVAGILIGLLSPFISQSIVDFGIGSGN
IQFVNTMLIAGMILAFSSMASDFIQSRLMLYVSERINMGMVSDFLRKTMS
LPITFFERKMVSDLLTRIDDHGRIQSFIMSTFLGIFINILLFVIYSLLML
YYESNMFLVFMIGNTVYTGWIFLFLKQRKKLDNQLFGCRATNQNDLLELL
ENVNEIKINNIANKRRWKWELSRFKIYGLRVKNMNLDQIEATGASFIIHL
QGLFITYIAALNVIEGTMTLGMMMAAQYILGQLNAPIKSMIGYVHSLQFA
RISLKRVNEVIWEEEPEISESKVSIPIEKGIKVKDLDFYYNPNLNKVLDN
INLEIPEGKITAIVGESGSGKTTLLKLLLRFYKPTNGEIEVGGVPLDNID
LYRWRNSCGAVLQDGKLFNDTILYNITLEDEEMNVNQKQLVKAIQLANAE
NFINARPLKLYTPLGTNGSGLSQGQKQRILIARAIYKNPDFIFLDEATNS
LDTNNEKQISKNLETILEGKTAIVIAHRLSTVKNAHNIVVMEKGKIVEQG
THQELINLKGIYYDLISSQLEIG
>BF1445 putative ABC transporter permease component
MIKQYFKQALAQLRQQPLLTTISVLGTALTICLIMVVVMQQQIKTTPFAP
ESNRNRLLHVKQMSTSNKNWSDDGSSNGPMGLQTAKGCFEGLTTAEEVSI
YTIPETMQVALPRGVRTGIDALETDGAFWRIFDFSFIDGKPYSDAEVKSG
LPVAVITESVARLLFGTSHQVSGKEILVNDAVYRISGVVKDVSSMASTAY
AQIWVPYSSTHITGGDNTWCDGIMGVMRVVILARSSSDFEAIRAECERRR
LAYNAGLGDYFVFYRGQPDDQLTMSQHKWANVQPDMAAYFRQQVIIFLIL
LLVPAINLSSMTHSRLRQRVAEIGVRRSFGATRGGVMGQIVAENLVLTLM
AGVVGLLFCLIISYCWGGTLFADSRLMYLNTAPVIEWKMLFKFSTFIYAL
LFCLALNLLSSGWPAWRASRMSIINALSGKLN
>BF1436 putative ABC transporter permease component
MNLMMILRQLWNQRAANGWILGELVVVTYFLWGVVDPVYVLLSDKALPDN
YDLTDTYLLSIGAYSANHTRYNPELDSDSLKQVDFMRIVDQVRRYPGVSD
VTVSFFNSYPQSGTWNGGQLFNDTIFANIQQMTFLSGTDYFGVFRIHDAR
TGEIPPVLAEGEQGIYLTPDVAEKLFGEKYPQNKWIHWGDSTRKSPLTAV
IDPLQIRSISQPGPLVFKATSELIHLPGAARICFRVRDGLASPAFTETFK
REMRPRMQIGNYYLASLTDFETVSKHFEYYMGTTGTIRLQIILASFFLLC
VFLGMGGTFWLRCNSRREEMGIYMTMGSTRHRLIRQFLLEAWWMVTIAFV
IGALAQFQVVYLNGFAFPPDDPNPDYIQNRPVLHFLIVSAISYILILAVS
FVATYIPVSKAARMNPADALRDE
>BF2458 putative membrane protein
MNYMIQHYLKTAIRNLLKYKTHSIISAICLSVGMTCFSIIHFFINEIDGA
SRNMPNFEQRISIRMINSNHEVGGWGWSLNSSEIRTLTEHPIPGIKQICF
HSFQREAEVVFINREQEEKPYIISYMDTDPNFFSHYNASFLYGNALPTTP
EEVVLSESCARKVYGKSNPVGTLLKIVKLKESEKDKSTYYKVVNVIRNLP
KTLDVETDIYFSHLREGNRQQGYITEGTLETADGLNKANESLKGITTLHN
NEMAYFIANKEADSYHDPQRMIGIAFITFLSSLILLSGMINFLKFIIQSF
YNRNRELALRKSLGASPKSLFALLFTEAFWMLTFSLLFSLVLSECTCLLL
TTYIPPKEMIPIDIQTLYGIQVKLYIGLLLICTLVMLYPIRRLQRSGLAG
HMKTNSHRHLFRNIMMCVQLCVCIFFLGMSIAIHLFNSVGSVLYLPLSDK
ETNSTLCFEMNSVTLGKNKDAILSQIKMLPGVENISSALMSGNYNSFLTS
DYESADHRTLTVRVRQGDPSYFQFFRIPFRGEIVEPHTSNVVYISEAFQK
QLENDSVSGNVKLGKENYRIAGTYKACYGENISEHNQYNISVFFPTEEAS
VIYIRFRDDISFGKAKSEIERVCRNYVPESLPLDIQRLDIRRSTTQGIRD
LMGDASLLLGIISALLVILSIYSAISMDTVSRQKEVAIRKINGATPKIIA
LMFGKAYIIQFILAYTITYPLLRLLVIDITKDSPISSITGFTWGIYLFIL
IGLLIFVTTAYKIYRIMHLNPAEIIKNE
>BF0366 putative beta-lactamase/acylhydrolase
MENKINFSPPSTREGKGVRFLLTTFSILLCSLQAVAQSLPRVAPEQVGMD
SHRLLHADEAIHRAIDHKEIPGAVLAVIRHGKMAYLKAYGNKRIYPNVEP
MEINTVFDMASCSKSMSTAVSVMILVERGQLRLLDRVSFYLPDFQEWRGE
NGEKKDIRIIDLMTHTSGLPPYAPVSELQEKYGSPNPKGLMEYISTCKRE
FKPQTKFQYSCLNYITLQHIIETITGQSLRDFAKENIFDILGMQYTDYLP
TIQQQDGKWINTVACPWMDRIAPTEKQKDGSVLCGQVHDPLARILNGGIS
GNAGIFSNANDIGILAAALLNGGEYNGHRILSPLGVKTMCTVPRELTAFG
RTPGWDIFSPYASNKGDLFSPNTFGHTGYTGTSIIIDPDNDTAVILLVNA
VHPEDRHSIVRLRSLVANAVAASICPPAQVYTDHYYKRFLQFETETPISP
KDIVMVGNSLTENGGNWSKRLNKKNIRNRGIIGDEALGICQRLFQILPGT
PQKLFLMAGINDVSHDLSTDSVVSLITKVIEKIQTESPRTKLYIQSLLPI
NESFGRYKTMTGKTDLIPEINRKLEALAKEKKIPFIHLFPLFTEKNSNVM
RKELTTDGLHLTEEGYRIWSKALKRYL
>BF1077 putative modification protein of type I restriction-modification system
MAIKKTQLYSILWESCNILRGSMDASQYKNYVLTMLFLKYISDKVQSDSD
IFFDLPEGCFFNDIVALKGKPNIGEEIQKKLHVIARANPRLDHIINEADF
DDSTKLGTGKAKVDTLTSLISVFQRDFLDFSKNRAGDDDLIGDAYEYLMK
NFAAESGKKKGQFYTPAEVSRLMARLIGIHKDNRPQISIYDPTCGSGSLL
LRAAAEYTKHRDGVSIFGQELDGATRGMAVMNMYLHGYDDPELEVGDTIE
KPFFKSTPNQLETFNYVVANPPFSQKGWIKGEIKINDTFGRWGNSDNLPP
IPPIGYEDYAFLLHIIKSINSQGRGACILPNGVLFRGNEEEAVRRKIIEK
RYIRGIISLPTNLFFGTGIPACIVIIDKAKTSTSKGIFMIDARSGFTKDG
AKNRLREQDIRRVFDAWEALENLEANGNLDDKEETIPHYARFVPYTEITN
ERNDCNLNVSRYITPVDTEIQQDLYAHLKLNGGLPTKDVEEGFSYLWRHC
PTLKNELFEPLEENYYKLRVGRNEIPNTIIHNKEFSTLSGFFSDAIEEWY
KLVSQQMFALAPGCQPKKLIADWSESLLEMLSEIDGLVDKYTIYDILLNY
WNSAMQDDCYLISRYGWTVELSCDVLTTDKKSKEVKFVPKKNPTFRDYNC
DLLPVHVVVNHYFKEENEAVNEAEERVSQLKGEIEQMEEEYPEELNDTVT
EIISKYIYAICPKPLKGEKDVLETYLAINEKGKIGKEKREAIIAKNRNVF
DRLSDMSVNAIKYRLKEVVNYAALPDDTIKLYKQYIDLNRELANAKTDVK
QKISKLTKLVVAKYPTLQESEIKGMVVNDKWHTAIVGGAISAAFDVTVDI
EQQVTALVDRYARRLSDIDASVRELEEKVNAHLAKMGFEL
>BF0155 putative AcrB/AcrD family RND transport protein
MKLDRFINRPVLSTVISIVIVILGVLGLLSLPISQYPDIAPPTVRVNTTY
QGANAQTVLNSVIAPLEEQINGVENMMYMTSTATNTGEASIEVYFKQGTD
PDMAAVNVQNRVAKAQGLLPAEVTKVGVITSKRQTSMLLVFSLYSSDDKY
DNEFLENYAKINLVPEVQRVPGVGDAMVLGADYSMRIWLKPDVMAQYHLM
PTDVSAALAEQNIEAAPGSFGEQGKQTFQYTLRYKGRLQSQEEFENIVIR
ANSDGQVLRLKDIATIELGRLTYGFSNNVNGHPAVTVIVFQTAGSNATAI
INDILDLLEKSESTFPPGVKVNISQNANDFLFASIHEVVKTLIEAFILVF
IVVYIFLQDLRSTLIPAIAIPVALIGTFFVLYIIGFSINLLTLCAMVLAI
AIVVDDAIVVVEGVHAKLDQGYKSARLASIDAMNELGGAIVSITLVMMSV
FIPVSFMTGTSGTFYRQFGLTMAIAIALSAVNALTLSPALCAILLKPHDP
DAKKKSTLASRFHASFNAAYDTVLKKYKKRVLFFIQKPVLTIGSVVVGFA
LLIFLMKVTPTGLVPNEDTGTIMAVVDMPPGSSLERTQEVMWQVDSLLAS
DPAIESRTMIAGYSFIAGQGPSYGSFICKMKNWDERSIAQRSDFVSGMLY
LKAREVIKDARVLLFAPPMIPGYSVSNGFEMNLQDKTGGSLDKFYEVAQD
FITKLQARPEIQSAQTSFNPNFPQYMIDIDAAACKKAGLSPSDILTTLQG
YYGGLYSSNFNRFGKMYRVMIQADPNSRTNLESLNSVKVRNGNEMAPITQ
FMSVKRIYGPDNIKRFNMFTAMTINGSPADGYSSGQAIQAMQEVAEQTLP
TGYGYEFSGMTREEQSSSGSTTAMIFVLCFVFVYLLLSAQYESYILPFAV
LLSIPFGLAGSFIFAHLMGLANNVLPILGAATNNIYMQIALIMLMGLLAK
NAILIVEFALDRRKMGMSITWAAVLGAGARLRPILMTSLAMVVGLLPLMF
AMGVGANGNRALGTAAVGGMFIGMICQIFVVPALFVIFQYLQEKVKPIEW
EDIDNTDAETEIEQYAK
>BF0509 putative ATP-binding component of ABC transporter
MIMRVDMDTCEEILVTITRNKTRSLLTAFGVFWGIFMLVALMGGGQGMQE
MMQAEFEGFATNSGFMASQKTGEAYKGFRKGRYWDIENADIERIRKKVKD
IDVITPSIARWGSTAIYGEKKYDCSVKGLYPDYAKIENQDMAYGRFINDV
DVREGRKVCVIGKRVYESLFNPGEDPCGKYVRVDGIYYQVIGMCVSEGNM
NIQGRASEAVVLPFSTMQQAYNMGKRIDVICYTVKPGKKVSDLEPEIEAI
LKEAHYISPDDKQAVMKLNAEAMFSMMDNLFTGIHVLIWMVGLGTLLAGA
IGVSNIMMVTVKERTTEIGIRRAIGARPKDILQQILSESMVLTTIAGMAG
ISFGVLILQLMEIGVNSGKDHYSHFQVSFGMAIGTCLLLVTLGLLAGLAP
AYRAMAIRPIEAIRDE
>BF2637 conserved hypothetical membrane protein
MIQRIQTIYLLLVTALLITSMCLPVGSFIGADAAMYVFKPLGVEMNGTLY
STWGVFGILLLSAIIAFATIFLFKNRMLQIRMTIFNSILLIGYYLTFLAF
MFVLKKDLSATFQISWALCLPLISIILNWLAVRAIGRDEVMVKAADRLR
>BF2172 putative transport-related membrane protein
MSAIRNITIGRTERLYKPVGYTMLANLVNIVPFCLSIEAIRIIFRAFNGG
GQSLDTTRLWCIFGCMTGYIAVMVLAERAAYRANFRGAYEMSASGRISLA
EHLRKLSLGFLGKRDPGDLSSMLITDFTMAETGISHYLPQLMGALVMPVL
AFVSLLWIDWRMAVAMFVALPFAMGILWLSTSVQERLSGRQIKAKVNAGN
RLEEYLQGIRVMKAYNLLGDRFVRLRDAFAELRRACIRLEALLGPFVLLA
ITLVRAGLTLMVLCGTYLLLGGQLSILTFVMFLVVGSRVFDPLTSALTNF
TEFRHFSISGGRILSLMNEPEMKGTKEAPEDGNIIFENVSFGYQEKEVLH
GISVILSRNSLTALVGPSGSGKSTVMKLCARFYDPTKGRILFGGVPVREI
EPEKLMSRISMVFQDVYLFQDSIRNNIRFGKSDATDEEIVAAAKKACCHN
FIMHLPHGYDTMVGEGGCTLSGGEKQRLSIARAMLKDAQIVLLDEATASL
DPENEVEIQKAIDTLIKGRTVIVIAHRLKTIMGADHIVVLSDGKVEEQGT
HSELMCRDGLYRKLWNIQESTLGWTL
>BF1841 putative type I restriction-modification system specificity system, partial
MNALAESLYYPKKSQELLKLKGLNSKWEQCFLKDVVENFCRRNKSHIQYP
MYSVTNDLGFVPQSEKFEERTMMGEDISSYKVINKGDFAYNPARINVGSI
AKYEGDNPCMISSLYVCFRPKYNISSEWLQHLLKSQRMIYNYNLFGEGGV
RIYLFFPNFGRIKISIPPLEEQKKIAAVISTIEQKISVENFILDKLNTQK
SFLLTKMFI
>BF4368 possible chloramphenicol acetyltransferase
MKHIIDIKTWERKENYEFFLGFQNPTISITSEVECSGARTRAKAAGESFF
LHYLYAVLRAVNEIKEFRFRIDSEGRVVYFDTVDMLTPIKVADNGRFFTV
RLPWYPDFKTFYTEAKAIISGIDPDKDPYEAEKTGGSDLLDVVLLSATPD
LYFTSLTCTQEHRHGGNYPLMNAGKAVIRGGVLVMPIAMTIHHGFIDGHH
LSLFYKKVEEFLK
>BF1611 putative FtsX-related transmembrane transport protein
MIGNYWNSAYRNLMKRKGFSFINVFGLAVGMASALLILTYVTFEFSFDKM
HEKYERIFRVESTFYEGEVQTDYWASSSFGYGSAMKENLAGIEDYTRVVS
LYQPEQIVKYGELTLRENQIAYADPGFFRLFDFELVKGDKATCLSMPRQV
VITERIARKYFQDEDPIGKILIFTGPYDKVVCEVTGVMKEMPSNSHIHYN
FLISYKSLGQYLHDYWYKHEVYTYVLLDSPERKEEIEKAFPAMSEKYKTD
EALKNKIWGVSLTPLADIHLKPQVGYEAEIKGNRTAMIALIFAAIAILAI
AWINYINLTVARSMERAKEVGVRRVIGAFRKQLVSQFLFEALVMNLVALV
LAVGLIELILPYFNQLVSRTVTFSVWLTGYWWLLLLIVFVGGIFLSGYYP
ALALLNRKPITLLKGKFLNSKSGEGTRKVLVVVQYTASMILLCGTLIVFA
QLNFMRNQSLGVKTDQTLVVKFPGRTEGMNTKLEAMKKAIARLPLVDKVT
FSGAVPGEEVATFLSNRRKSDALKQNRLYEMLVCDPDYIDAYGLQLVAGR
GFSEDYGDDVNKLVVNESAVRNLGIASNEEALGEEIEVECTDASMQIIGV
VKDYHQQALNKNYTPIMLIHKDKIGWLPQRYISIVMKSGDPKELVSQVEE
IWHRYFEDSSYDFFFLDQFFDHQYRQDEVFGVMIGCFTGLAIFISCLGLW
VLVMFSCTTRTKEMGIRKVLGATRWNLFYQLGKGFFQLILIAVIIALPVA
WFSMNAWLSHYAFRTDLKIWFFAVPVVLMLLISFVTVACQTVKIIVGKPA
RSLRYE
>BF2099 putative ATP-binding ABC transporter protein
MIKAIGLTKIFRTESVQTIALNEISIDISEGEFVAIMGPSGCGKSTLLNI
LGLLDNPTSGELWFIGKEVSRYSENDRTDMRNGNIGFVFQSFNLIDELTV
FENVELPLLYAGVPVRERVDRVNKALERMQIGHRTEHYPQQLSGGQQQRV
AIARAIVTNPKIILADEPTGNLDSTNGNEVMLLLKELNKDGATVVMVTHS
EENAREAGRIVRMMDGCILTENRR
>BF1934 putative ABC transporter ATP-binding component
MNKTVIELQNIKRNFQVGDETVHALRGVSFTITEGEFVTIMGTSGSGKST
LLNTLGCLDTPTSGEYLLDGISVRTMSKPQRAILRNRKIGFVFQSYNLLP
KTTAVENVELPLMYNSGVSASERRRRAIEALQAVGLGERLEHKSNQMSGG
QMQRVAIARALVNNPAVILADEATGNLDTRTSFEILVLFQKLHAEGRTII
FVTHNPEIAQYSSRNIVLRDGQVKEDSTNPDILSAAEALAALPVQEE
>BF0940 putative ATP-binding component of ABC transporter
MDSIHLQQTLPQVFADRNSITSDVWHRNLVFHKGKSYLIEAASGTGKSSL
CSYIYGYRNDYQGIINFDETNIKAYPVKQWVEIRKHSLSMLFQDLRIFTE
LTAIENIRLKNNLTGYKTRKEVLSLFEALGLSDKLNVKAGKLSFGQQQRV
AFIRSLCQPFDFIFLDEPISHLDDNNARIMGELVMEEASKQGAGIIVTSI
GKHIELTYDRILKL
>BF1527 putative cation efflux protein
MCSLAVLAAYMFRHIDKKAYGLYWHIDITILKEVFSISVWSMLQFFTSVA
IWFLFFVAIERLGEKELAVSNIVRSVSALFSVIVNALAGVTGSLVSNLIG
AGEKKKVFPLCHKIIRLGYATGIPLITFALFFHQHIIGAYTENPAIIQLA
WPPFLVMLLNYFFALPGYVYLNATTGTGATRTVFIFQVITTIAYLFCLWG
LGYCNVTLAAYWAVEYLYVILLGTQSVIYLKYKQY
>BF2211 putative ABC transport system, ATP-binding protein
MIQISDISKVFRTSEVETVALNHVSLNVEEGEFVAIMGPSGCGKSTLLNI
LGLLDNPTEGSYKLMGQEVAILHEKERTRVRKGKLGFVFQSFNLIDELNV
YENVELPLTYLGIKASERRQMVNNILHRMNISHRAKHFPQQLSGGQQQRV
AIARAVVTNPKLILADEPTGNLDSKNGAEVMNLLTELNHEGTTIIMVTHS
QHDASFAHRTVHLFDGSIVASVKA
>BF1458 putative type I RM modification enzyme
MAVNNIIKRIRNIMRQDAGINGDAQRIEQMTWMIFLKVYDTQEETWEYKA
SRESKTYQSIIPKDLRWRNWAVDEKDGEALTGEALLSFVNEKLFPALKNL
PVDANTPRAKSIVQETFADLNQYMKNGTLLRQVVNIVNEIEFDDADDRHT
FGDIYEGILKDLQSAGNAGEFYTPRALTDFIVMMLDPKLGETFGDFTSGT
GGFLTSALNYMGKSVRSAEDGEKLQNAVVGQEWKPLPYLLSITNLLLHDI
EAPNIANCDSLGTNVTDFKETDKVDVIGMNPPYGGSTEDSVKNNFPLRYR
SSETADLFIALIMYRLKAGGRCGVIIPDGFLFGTDGAKLALKENLLRKFN
LHTIIRLPGSIFSPYTSIATNILFFNNEEAEGCEEGFKTKETWFYRLDMP
EGYKHFSKNKPMKVEHTLPIQEWWNDRKEIVSSETGEKSRVFTAQQLLDL
NCNFDQCKFPKEEEEILPPAELLKQYFEKRAALDYEIDKTLSEIQKILGI
DIKSCN
>BF0387 putative ABC transporter ATP-binding protein
MIHLEGITKSFGSLQVLKGIDLEITQGEVVSIVGPSGAGKTTLLQIMGTL
DSPDAGMINIDGTNVSRMKEKELSAFRNKHIGFVFQFHQLLPEFTALENV
MIPAFIAGVPTKEASMRAMEILDFMGLKERASHKPNELSGGEKQRVAVAR
ALINQPAVILADEPSGSLDSHNKEELHQLFFDLRNRFGQTFVIVTHDEAL
AKITDRTIHMVDGNII
>BF1839 putative type I restriction enzyme, partial
MTIEMKNNKNNNCNFPTLRFPEFSGEWKKDIIGNVISVKSEKYNPHSNRT
EFICVELESISQGTGELLETFNSAEQKSIKNKFSPGTVLFGKLRPYLRKF
YLPYFEGVCSSEIWVMRSNKIEPAFLYSFIQTPYFISLANQSSGSKMPRA
DWGLIETSKIAYPPNSAERVKIGKFLKLIDERIATQNKIIAHLESLIKGL
TNQLLIPNSNWQPTTIGQVLTINPGKDYKHLKEGNIPVYGTGGYMLSVND
YLYDGESVCIGRKGTINKPIFLTGKFWTIDTLFYTSNFNSLLPRFGYYLF
KTIDWLKYNEASGVPSLSKVSIEKIHISLPSLAIQNSICRLLDSIYDKLA
LEESVLNNHQTQKAFILQQMFI
>BF3936 putative ABC transporter transmembrane component
MGKIEIRNLCFRYGKQMVLNNLNLDIPENALYGYLGNNGSGKTTTIQVLL
GLARPVKGEVLYDGQPFRDQREKQLRKIGLCPGEPFYYDNLTGYEHLAYL
DHIYHCGRTAINKVLAITGIENARNKKLRHYSTGMIHRLGMAMALLHDPD
ILFLDEPLNGLDPEGIHSIRELLLQLHQEGKTVFLSSHLLDEVEKTCTHV
GILQHGCLLYQGDLSELLNSIEKRIHIRLDKVDLLHSVCKEVQIDSRIKS
ESILEVILSNDTTYDRLIELLGQGGYHISAIQPLENTLESVYLKLTSQTK
>BF2216 putative MatE-family transport-related membrane protein
MAQQTDPRILGTEPIGKLLLQYSIPAIIGMTITSLYNIIDSIFIGHGVGP
MAISGLAITFPLMNLVVAFCVLISAGGATISSIRLGQKDIKGATDVLGNT
LMLCLTNAVLFGGLAYLFLDPILFFFGASTGTLPYARDFMQVILLGTPIT
YTMIGLNNVMRATGYPKKAMLTSLVTVIANVIIAPVFIFHFGWGIRGAAM
ATVLSQFIGMIWVVNHFRNKESFVHFMPGFWKMKKRIIGSIFSIGMSPFA
MNVTACIIVILINNSLQKYGGDMAIGAYGIINRLLMLYVMVVMGLTMGMQ
PIVGYNYGAQKIDRVKHTLRLGIIVGVLITSSGFIICELFPHTVSAIFTD
SDELIDMASSGLRICTLMFPFVGAQIVISNFFQSIGMAKISIFLSLSRQL
VYLLPGLLLLPPLYGVKGVWISMPVSDGLAFVTAVVILMVYIKKVKEKTS
GQKL
>BF2212 putative ABC transport system, membrane protein
MMKQFYYTIQTLLRGQGNNMIKIVSLTLGLFVGILLFSRVAFELNYDSYY
QEPENLFLTLRTVVSQGEKKEPVCSNYGKLPAAIRENFPDEVEDATLIDL
FSRSSLYHEGQEKKDAILATSRSHIFSTLGVKVLSGNVSELDNMDALFIS
RSLAQSLFADADPIGKTVMINIDYPLTVRGVFEDIPENAEFRFDGVYSFV
TRANRFRDERGGWRGDISYTCMVRFRHPEDVEKVAARMPDMMKKYIQYNK
DWFEEFSFITPSQFHLQKKESRKIISILSILGFAILLIAGMNNVLISISS
LPQRAKSVGVHKCSGASTGHIYRMFLWESALLILVSLLGVIVLLLYFKPE
IEDLSGASLATLFTWRTLWVPALVTIFLFLLIGLLPGKLFSSIPVTQVFH
RFTGYRASWKYPLLFVQFTGVAFILGLLMIILLQYNQVMNRSMGYKIDNL
VIGWGPFDSMDKIDGILRGLPFIEASCNSASFIYNGHTRQSFTDINGKRF
MGCIDFIDEHYVPILGLQILQGRNVHQDGEVLVNEELLRQVGWTDSPIGR
KLMEDNYEWGTVVGVVKDYVAQSAYQPQASVALVNSLERRWEANKRNLIL
KEPFKENLSRIRALMKETFPTEDIQFRSARQEVDNLYQVVRRFRNIVIVA
SVSIVVIVLMGLFGFVNDEVQRRSKEIAIRKVNGAESGNIINLLNHNIFW
IALPAIFVGIALAYVVGHKWVEQFTDQINLNAGHFLLLLLLILLLILGSV
TGKSWRIANENPVNSIKNE
>BF2648 putative ABC transport system, membrane protein
MIKYLIEKEFKQLLRNSFLPRLIFIFPCMIMLLMPWAANLEIKNIRMNII
DNDHSVISRRLVDKITASTYFQTTALPDSYEKGMEAIEAGTADLLLEIPR
GFEKDWVNGGAANVLLAVNAVNGTKGGLGSSYLSAIVNDYGEELRTESGT
TSFSADGNLPRIDILTQNLFNARLDYKLFMVPALMVMLLTMLCGFLPALN
IVGEKEAGTIEQINVTPVGKFTFILAKLIPYWLIGFVVLTLCFVLAWTLY
GIFPVGHFWVIYCFSIVFVLAVSGLGLVISNHSATMQQAMFVMWFCMLIL
ILMSGLFTPIRSMPEWAQWITMLNPLKYFMQVMRMVYLKGSGFIDLLPQL
GALLAFALLFNVWAVKSYRKSG
>BF1438 putative ATP-binding component of ABC transporter
MITLTSLSKIYRTNEIETVALENVNLKVDRGEFLSIMGPSGCGKSTLLNI
MGLLDAPTAGTIEINGTHTEGMKDKELAAFRNKTLGFVFQSFHLINSLNV
MDNVELPLLYRHIASSERRKLAQEVLEKVGLSHRMRHFPTQLSGGQCQRV
AIARAIIGNPEIILADEPTGNLDSKMGAEVMELLHRLNKEDGRTIVMVTH
NEEQAGQTSRTVRFFDGRQVQ
>BF3596 putative cation transport related membrane protein
MKDSIDFGNMEIPRLFRKLLIPTVLGMVFSAVFVITDGIFVGKGIGSDAL
AAVNITAPLFMITTGIGLMFGVGASVVASIHLSQGKRKVASINITQALAF
SALLILVLSALCCYFAEPIGRLLGSSERLLPLVVEYMNWYVPFLVFYLLL
SAGMFYIRLDGSPNYAMMCNAVSAIINIILDYVFIFQLGWGMMGAAFATS
LGTMVGGLMTLIYLLRFSRNVGIYRIKLSRKSMRLTCRNIGYMIRLGSSA
FISEASIASMMFLGNYVFISHLGESGVAAFSIVCYFFPIIFMVYNAIAQS
AQPIISYNFGQQNPGRVARTIRLALKTALGCGIFFFAATLVFNHQIVGLF
IDKSYQAYDIAVNGIPYFAVGYLFFALNIVGIGYYQSIERARRATVITLF
RGTLFMLAGFLLLPPVLGVRGIWLAVPLAELLTLLLIIGIYLKDSFAVRR
>BF3926 putative transmembrane transport efflux protein
MRLIYKNHYKALFLLGLPIVIGQVGVIVLGFADTLMIGHHSTNELGAASF
VNNMFTLAIIFSTGFSYGLTPIVGGFYGTRRFASAGQALRCSLLANLLVG
ILLTVIMGILYLNVERLGQPEELLPLIKPYYLILLASLVFVLLFNGFKQF
TDGITDTKTAMWILLGGNVLNIVGNYILINGKLGFPELGLLGAGISTLFS
RIVMVLVFAFVFFSSRRFLRYKLGFIRLGWSRTLFRQLNALGWPVAFQMG
METASFSLSTVMVGWLGTIALASHQVMLTISQFTFMMFYGMGAAVAVRVS
NFKGQNDIVNVRRTAYAGAHIILAMGVVLLSIVFLFRYQVGGWFTDNTEV
SAMVVVLMVPFLAYQFGDGMQINFANALRGISDVKPMMLIAFIAYFIISL
PAGYFFGFVMGWGLLGVWMAFPFGLSSAAIMLWLRFRYKTR
>BF3310 putative transport-related membrane protein
MNYTYRQIWLINYPVMLSILMEQLINITDAVFLGHVGEVELGASALGSIY
YLAIYMLGFGFSLGVQVMVGQYNGKGHYTGTGRTFFQGLVFLCVLAILLS
LSSYFFSPFLLRYFVHSSEIYCAVIDYLDWRCFGLLFSFPFLAFRSFYIG
IVRTNALSWAALAAVLINIPCNYWFVFVLDRGIAGAAIASSLSEAASLLI
IMVYTWLKIDRTDFGLKFIFDKCLLVELWHLSVWSMLHAFISVAPWFLFF
VVIERLGEAQLAVSNIIRSVSTIFFVIVNSFAATTGALVSNLIGAGERQY
LFPLCRKILKLGYAIGLPLVVLAMVFRRQITGFYTDSSQLINISSIPFAV
MLLNYVFALPGYVYINAVTGTGKTRIAFWFQLITIVIYLFYLYLLSHYTA
SLAVYLTAEYLFVILLAVQSVLYLRISS
>BF2454 putative ABc transport system, membrane protein
MIRHYFKIAFRNLLKYKTQSIISIIGLAVGITCFALATLWIRYEMTYDTF
HRRADDIYLVRAQLTITDGTLSNSMPYPAIEYLRKNISEIEDICGISPFK
TNLRFKDKGGDLLAIEVDSAFIRMFDVRILQGNVNFLKKKSNEIAITEAV
AKEWFGNESPLGKEIELGSRPCKVCAVVSGWSQHSNLSYGALLPARHHPS
WQSNSEQIFVRILPDTDKSALQKRISSLDASSQEKESTLGKLNFTPITSL
RYSDYLQKDEIVISFNYIRYFAMAGVLVIVCSLFNYLTLFVSRLRMRGRE
LGLRKVCGSTNRSLFALLSVEYLIVLLAGSLLGMAFIEACLPHFIELAQI
SEATPLYTEVIIYILAVIVLSFGISQIPLYYFRSRTLQSSIRNKKGSPQR
GIFRRLGLIAQLIISLGFIFCTTIMMKQLYYLKNTDLGIERHNIGNVAVW
MKGDINEWSSKIANLPMVTEALPPHYFPIVPTGPMMYTDINGWDGLNETT
DETYSVGLIPSGKEFFDFYGLQLTEGEWLSEKNSPGDVIINETAALTFGW
RNPVGKQFYSEYEHNRTYYTVVGVVKDFSYLPPTIAPRPLAFVRTEEQKY
LWSRASILFKFTEGSWEACKDTIRKMKEEDFPSSFLRLYNEEEEYNKYLR
SESALMTLLGIVSIVCVIISIFGIFSQVTLSCEQRRKEIAIRKVNGATIG
SILQMFIKEYFVLLLVAALIAFPASYGMMRVWIESYVRQTSTPFWIYIVL
FAGIGIIIVISIFWRVWNAAKQNPAEVVKTE
>BF3192 putative transport-related membrane protein
MDISKWAFHNRNLIYFLIAVLMFGGAYSCYQMSKLEDPEIKVKLAMVITT
YPGASAHQVELEVTDVLEKNIRTMGNIDNIESYSYNDLSLIQIELLSTVP
DDDVEQCWDMLRRKVNDARASLPEGVSAPIVKDDFGNVYGMFYALTGDGL
SDRELSDYAELIKREVGELEGVDRIDLYGKRPECINISLLQDRMANLGVK
PAEVLATLNGQNKTTYTGYYDNGDNRIRVTVNDKFKTVEDIGKMLIQGHD
DDQLRLSDIAQIEKGYEEPVRNEMYYDGERALGILIAATSGSDIVKVGHA
VEARLAELKAERLPAGVEYQKVFYQPERVGESLGTFVINLIESVIIVVLI
LMIAMGFKSGVIIGISLVVTVFGSFLFLYSAGGTMQRVSLAAFVLAMGML
VDNAIVIIDGILVDLKAGKDRMEAMTAIGRQTAMPLLEATLIAIIAFLPI
YMSPDTAGVYTRDLFIVLAVSLLLSWVLALVHVPLMANRRLHFAVEADSG
GKRVYKGKIYAALRTALRFGLAHRWSFVFTMVGLLALSVFGYQYMRQGFF
PDMVYDQLYMEYKLPEGNNYTRVEQDLKEIEAYLKGRKEITHVTASIGGT
PGRYNLVRSVANPSLSYGELIIDFTSPEELVDNMDEIQRYLSATYPDAYI
KLKRYNLMFKKYPIEAQFLGPDPAVLHQLADSARNIMKNTPEVCLITTDW
EPQIPVLTIEYDQPAARALGLSRSDVSMSLLTAAGGIPIGSFYEGIHKNN
IYLKCLDKEGQPIEDLGNTQVFSALPSLNGLLNEETMVKLKTGTLSKEDL
VESMMGSTPLQQISKGIDIRWEDPVVPRYNGQRSQRVQCSPAPGIETEKA
RLTIADKIEQIRLPDGYSLVWQGEKIASDQSMKYLFKNFPLAIILMIAIL
IMLFKDYRKPIIIFCCLPMIFVGVVGVMLLTGKVFNFVAIVGTLGLIGML
IKNGIVLMDEITLQINAGIEPVTALIDSSQSRLRPVMMASLTTILGMIPL
LSDAMFGSLAAAIMGGLLCSTLITLLFIPILYALFFKIRND
>BF0933 putative ATP-binding component of ABC transporter protein
MITIHNLRKNFGTQTAVDIENYTINQGEMVGLVGNNGAGKTTLFRLMLDL
LKADTGEIIINDIHVNQSEDWKSFTGAFIDDGFLISYLTPEEYFYFIGKM
YGLKKEEVDERLIPFERFMNGEVLGQKKFIRNFSAGNKQKIGIVSAMLHY
PKLIILDEPFNFLDPSSQSVIKHLLKKYNEEHNATVIISSHNLNHTVDVC
PRIAVLEHGVIIRDLVNENNSAEKELEDYFNVEEE
>BF3941 putative ATP-binding component of ABC transporter
MKMITVENLSFLYRKSKRAVLHDFSLSLEKGRVYGLLGKNGAGKSTLLYL
MSGLLTPKSGKVVYHDVDVRRRLPITLQDMFLVPEEFDLPPVSLISYIEL
NSPFYPRFSKEDMVKYLHYFEMDINIDLGALSMGQKKKVFMSFALATNTS
LLLMDEPTNGLDIPGKSQFRKFIASGMTDDKTILISTHQVRDIDKVLDHV
LIMDNSRVLLNESTMSICDKLFFTESENRELLQSSLFSTPSIQGNFLLLP
NESGEDSEINLELLFNATLAVPERISALFHSKQIEL
>BF2917 putative restriction enzyme related protein
MKELGFTIVHKEKNPNFYETLTKFLEQTKTKSQKYKDYPKEFLGLNISVS
FGIGGPSKTPWISFLYDGQKTQHGIYPVYLYYKEYNTLFLAYGVSETTPP
NIEWKFNTSPETIFDFFKRKGIKPKRYGNSYVFKDYDINNLNPSTINKDL
FEIIENYKNLMASYTEISTNTNKMQSPSINIDYQSIPANLRQFVTAIKSK
PFILLAGISGTGKSRIVRQLAYATGGENPEKVQKPYNYEMISVHPNWHDS
TELLGYVTRVSGNPEYIVTDFLKFIAKAWFYEGIPFFLCLDEMNLAPVEQ
YFAEYLSVVESRKLRNNKIVTDPIVPPLTTWDKADQKTLVSDQILKELFH
EFWNNEGWNNSTIAARIEELKEQFKNTGISIPQNLIVMGTVNMDETTYSF
SRKVLDRAMTIEMNHVDLNSGLSKAQDNITPITAKALLPEVVEGYDVYEQ
NPEICKSIIKYLQQVNEKLEDSPFKIAYRTRNEFLIYVLANLPYQGKETQ
EQCITRALDEITCMKILSRIEGDKNKVGTVLDDLYTIIQKRIETSGINSE
KSISLDKIRRMKKKLETAYYCDFWN
>BF0511 putative ABC transporter ATP-binding protein
MIHLKDINKTYNNGAPLHVLKGINLDIERGEFVSIMGASGSGKSTLLNIL
GILDNYDDGEYYLNNVLIKDLSETKSAEYRNRMIGFIFQSFNLISFKNAV
ENVALPLFYQGVSRKKRNALAMEYLDKLGLKDWAHHMPNEMSGGQKQRVA
IARALITQPQIILADEPTGALDSKTSVEVMQILKDLHKTGMTIVVVTHES
GVANQTDKIIHIKDGIIERIEENLNHDASPFGKDGYMK
>BF1609 putative FtsX-related transporter permease
MNYISQVIRSQRVKKSLTLINITGLSVCIAAALLIMLYVWSELSYDSFHD
TDRVYRVESRLYEGEMLTDNWATTAYGHAPAMNREIAGIEKYVRVTAQDR
EQVVNYFDRRFAEEHYCYTEPAFFEIFNFPIVKGEKTGQLVRPNTVVLTE
SAASRYFGEEDPIGKILTFSTSSSQQNFEVTGIIADMPVRSHLHYDFLLS
YNTIPKERQDIWYIHGVYTYVRLMPGKTPGEIEQAFRDISDKYKTDALKH
KTWAVELISLKDIHLTPQKAYEKEVKGSRTAVLILFVMSAILLLIGWANA
LNLTVARFLERGREFGLRKAFGASRRQIIIQGLLESGFMNLLATLIAFGW
LELLLPLVYRWAGQNFGTDILMQPAFWGIVAGVVIIGTLVVGLYPSWLMV
TIRPSEIMRGKLLHGKRGNRIRKALIVVQFLASFVLIAGTFTVFQQVRYM
QREAESDLNTRILVIKYPSFTEGLSLRMESFTKRLKQRADVSHVTVSGAV
PGVEVANYFTNRPYGSDPSQVKLIQMFSVDYDYLSAYMPRMICGRSFSED
YGGDLNRVVLNEEAVRLLGYESAEAALGQQLKMEVVSDPLEIIGVVENYH
QQSLAVAYKPIIFFLKERVPFIATPYISVCLKGKGDAGVLTEIEQMYREY
FPTSLFSYFFLNDFNEFLYKSDRNFGWIFASASLLAVFVACLGLWIVTLF
STLSRLKEVGIRKVLGANKTSLFFVLTKELLLLTVLASAIGIPVSAVLMN
AWLETYAFHISLSWWIYAATFVLLMLIAFLTVLQQVWRTIRQKPMRILKY
E
>BF2487 putative chloramphenicol acetyltransferase
MKQLIDLENWNRKEHFKFFSAFDDPFLGITTLVDFTNTYHQSKDEKKSFF
LYSVHFLLQCVNEVEAFKLRIEGEQVVKYDFIHLSPTIGREDGTFGFGFF
EYDADLEVFIQNAEKEIERVKNSTGLSFSENIGRLDLIRYSALPWFAFSE
MKHAVSFGRGDSVPRISTGKLIKENGAYLLPISISGHHALMDGRNVAELI
EKLETTKK
>BF3136 putative HlyD-family secretion protein
MSTRQIKLKQLRRLKFRNIFLNTVCILLALAGISWTVNYFWKYARYEITN
DAVVDQYIAPLNIRIPGYIKEVRFTEHQYVHAGDTLLILDDREYRIRLKD
AEAALMDALGSKEVLNSGIRTSGVNVAVQEANIAETLAHLSQQEAELNRY
TRLLKKQAVSQQDYELAKANFEATRARYNALLRQKEAAQSQYSETSKRST
GAEANILRKEADLEMARLNLSYTVVTAPYDGYTGRRTLEPGQFVQGGQTL
SYLVRGNDKWVTANYKETQIAHIYIGQKVRIKVDAFSGRTFHGTVTAISE
ATGSKYSLVPTDNSAGNFVKVQQRIPVRIDLNDASPEEMECLRAGMMVET
EAVRP
>BF1840 putative type I restriction endonuclease specificity subunit, partial
SLIKGLSDTLLENPLWQKTYLRSFMQFYSTNSLSWGQLSYEEGEIRNLHY
GLIHSFQTSEIDTDSLPRILPANVPKQYTLCQAGDVAFADASEDTDEIGK
AVEFIRTHKASVICGLHTIHGRDIKCKTLLGFKRVAFNSHYFHDQIKRLA
QGTKVFSITSSNLSSCYIYIPDIVMQKSIVVLFEAYEEQLITNKRLLEQY
EKQKRYLLQQMFI
>BF1434 putative ABC transporter permease component
MKNLWARRRKNGWLLAELILVSIVTWVIVDPLVVLTHDRNLPEGYRPDHL
FLLQLASYPAGSEQFRAEENDTLARKANFERLLNKLKHYEGVKYTTFILN
EQYPSALSISNGNTMFDTIPVRTLRLAFIPHTDYFRTMGMEGAEGMTAEQ
LDNRDFLWTESVLTADISQRLKDGKPLYGRRLGNGDEEDYRVGGVIAPVR
YRSYMQPMPIELYVYEEFPDYMYYYIPLIALRIDDHLSEKVFLHHFREWM
NKELTVGNYYVKSVQSFSDIQEQHEFSEGITNQYRLNLALGIFFLVNLCL
GVAGTFWMQTRSRREEVGIMLSFGGTPSHITRLLLYEGWILTTLGTLTGC
LLYLQYALRDGLYTTCNSAEEAMPAYWINHFGLHFTAVTLIVYLLLLIVV
SIGIWMPAHKLSRISPVDALRDE
>BF1435 putative ABC transporter permease component
MIKLYFKQAWQLLKQNPLFSSVYVLGTGLGIAMTMSLVIIYYIKMAPVYP
EENRNRILVSKGMTAIEQGDENNWFSSNVSFQTVKRFYYPLKSAEAVGCS
LDGHTTSLLELPESKDLKEVQVKLVDAGFWKVFSFAFVDGKPFTRADFDS
GLRKAVISVTLARRLYGDNAPVGRTFVLDSDEYQVCGVVKDVSFITPATY
ADIWLPLTVDAEVVEEKEGSYELIGNLSVYMLAPSVGSKDKVAGEVRDAF
RKYNFSQKKYKVDLYGQPVSYWKSTFYEYCNSAPDWGKLIRTYGTILLAL
LFVPALNLAGMIASRMKRQLSEMGIRKAFGASKASLLMQVFWENLFLTGL
GGLLGLLLSYLIVYCGRNWLPDLLSAYSDVIPEGVDSFLTPGMLLNPVVI
GITFLVSLILNVLSALIPALHALKKDIVYSLNDKR
>BF1879 putative transmembrane Na+ driven efflux protein
MNDKYEERLGTDRMLPLVFRMALPAVIAQIVNLLYNIVDRIYIGHIPGIG
TQALAGIGVAGSLIILISAFSAIVAGGGAPLAAIALGQGNRTHAGKILGN
GFVLLLFFTLLTSGLSYLFMEPILLFTGASEQTLGYATAYLSIYLIGTLF
VEVSVGLNTFINTQGRPGIAMLSIVIGALLNILLDPLFIFVFDWGVKGAA
LATIISQACSAGWVLFFLTSRRASLRLEPRYMRLDRKVVGAILALGASPF
IMASTESLVGFVLNGSLKTFGDIYVSALTIMQSAMLFVSVPLAGFALGFV
PIVSYNYGHGNRERVKECFKIVMTFMFLFNLVLILLMILFPSVIASAFTS
DEKLIETVVQVMPVFLAGMTIFGLQRACQNMFVALGQAKVSIFIALLRKV
ILLIPLALMLPYLMGVMGVYAAEAISDAAAAICCTVIFAVQFPRIMNKLT
VRS
>BF1078 putative modification protein of type I restriction-modification system
MIETKFKQTELCRIPEDWDIGTFADFLITFSAGATPYRGIPDNFVGTIPW
ISSGELNYCEIENTREHISSDAQKNTHLTLHKPGTFLIAITGLEAAGTRG
RCAFVKTPATTNQSCLAINSTDKMTVKYLFWFYRQWSDFLAFNFSQGSKQ
QSFTAEIVKRLPLYAPKYKEQEKIAEALSDVDKLIRELDTLIEKKRAVMQ
GTMQELLTAHRRLPGFVHPWRNTLVEKCCKITTGESNTRDQIESGIYPFY
IRSATVMRSNSYIFDCEGVITIGDGQIGKVFHYVNGKFDLHQRCYLMYDF
DDIDVKFFYFLFSFFFYNRVIALSAKATVDSVRRNMIAKMKINIPSTMQE
QKAIANILSDMNDGIEAIEAKRDKYIAVRQGMMQQLLTGKIRLI
>BF1122 putative restriction enzyme of type III restriction-modification system
MKIKYKHQRFQAEATRCVTDVFQGQPKRDGLSNFLIDQGKGHIGFKVEGF
GNAPIVLDRESLCENIRTIQMAQGLKPIEHIQGEGLTLTVEMETGTGKTY
TYIKTMYELNQRYGWSKFIIVVPSIAIREGVFKSFESMAEHFAGEYGKRM
QYFIYNSKQLSKIDGFAQDNGIHVMVINTQAFNASMNEEKNIQGRSGDAV
ARIIFSRRDEFGSRRPIDILAKTNPIMIIDEPQSVLGTDKGNATRRGIQL
FNPLFKVLYSATHRKDDIYNMVFRLDAIDAYNKRLVKKVEVRGVHQLGST
ATNGYVYLDEIVIGKGNPQARIGFDMKTNNGTRHVIRLAGEGFNLKEQSG
GLQEYEDNYIVERIDGLTGTIHFLNELTLHEGDIVGAANEELVRRMQIRE
TIKTHLERERQLFPRHIKVLSLFFIDHVDSYRIYSKEGVEKGKFAKMFEE
EYQRALQEMMPTFTDGAYMRFLSDPKNACDNIHDGYFSVDKKGVSVESKS
KEGENEERGFNLIMKDKERLLSQECPVRFIFSHSALKEGWDNPNVFQICT
LKDTANEIKKRQEVGRGMRLCVNDKGERQDTDVLGDTVFNINILTVIASE
SYDDFAKKLQKEIAEACDTRPVIVTANLFADAMAQTEDGTTVKISTQQAV
DIHEELITQGYIKKGKLTQKYFDEKKAGQLDFGEANELKSFIIKQLDKVF
DPDSVKPTNGREKKEAKFNADNFHKKEWQELWKRINTRTYYNVNFDTSKL
IKNAIDELYKHLNVTEIRIVVESGGIEGIRDREELEVGTAMSAAKVRTIH
VKEAVGSGVTYDLVGELVQATGLTRRTIVAILQGIKPTTFHQFKLNPEEF
IIKAGRIINDCKAISLIQHIRYEKRNNTFDSDIFEEATLRGTLGKDAIES
EKSLYDLVVVDSQGIERSFAESLEKEDDVVVYTKLPGGFYINTPMGKYNP
DWAVAFREGSVKHVYFVAETKGNDIEASQLRKAEDAKIECARRHFAAIST
GEVVYSVVKTYQDLYNAVTK
>BF3145 putative membrane protein
MKTIKFKYLLPCALLGMMLGVASCVNDLDTVPLDKDELVSDVVFGNEPLA
YEQSLAKIYAGMAIGGNSGGDSDQDVVGIDGGSQASFLRVLWNMQDLPSD
IAHCAWNDPGIPEFNHISWGASSPWIKGSYYRLFYQINVANAYLRETAED
KLDARGCDASLKASIKTWRAEARFLRALSYEYALDLYRNVPFVDENSPIG
SIPPKQIMAADLFNWIEKELTECVEDMLEPTVGYSQDYGHANKAAAWALL
SRLYLNAETYVGQNKYTECITYAKKVIETGYQLEPVYVDMFKADNHLSNE
MIFPVRYEGDQTMTWGGMTAFLCWGATATQEEVNAKGAWQGVRAKSSLYN
LFLKESGSDADTRKAMLRTDLTTSLEIIDENTFQNNGIPVTKYFNVNKDG
TLPPSKEAYVDFPLFRLGEIYLTYAEAVLRGGQGGDRATALRYVNDLRKR
AYSDKTLAPISDSDLTLNFIIDERGREFFFEGQRRTDLVRFGLFTTAGYV
WPWKGGTAKGKAVENFYNVFPIPSDDIGSNTNLKQNEGY
>BF2785 putative N-acetylmuramoyl-L-alanine amidase
MRKIDLIVIHCSATREDRCFTEFDLDVCHRRRGFNGPGYHFYIRKDGRIV
STRPVEKIGAHAKGHNATSIGICYEGGLDARGRPKDTRTEWQVHSMRVLV
KTLLKQYPGSRVCGHRDLSPDLNANGEIEPEEWIKQCPCFNVIEDKKLH
>BF1842 putative type IC restriction-modification system specificity subunit, partial
MRFPEFSGEWKKYFIRDIAEVTKGAGISKEQRSLFGTPCILYGELYTTYK
SEVINDVQSKTDIDAKNLVRSKENDVIIPSSGETAIDISTARCVPYDDVL
LGGDLNIIRLYQNDGRFLSYQLNGVRKLDIARVAQGSSVIHLYGESIKSL
SVSLPALKEQQKIVSLLSLIDERIATQNKIIEEYKKLKNALAELFFAKSI
EYTSIGEMCDVVMGQSPSSVAYNYTKNGLPLIQGNLDIFEGVTSPRMWTS
DITKQCDIGDIILTVRAPVGDVAKSNMIACVGRGVCAIKVKESGCSEYVY
QYLLYFKAKWGSIEQGSTFSAISRNDILNINIPVITKRLIVASHLLALFD
SEISIEALNLNVYTKQKQYLLTKMFI
>BF0188 putative transport ATP-binding protein
MKEFFQLMRRFVSPYKKFLGWAVFLNLLSAVFNIFSFTLLIPILQILFKM
DNKVYEFIPWDAAGEGLKDIAVNNFYYYVTRMIEINGPSLTLLFLGLFLA
FMTLLKTSCYFASSAVMIPLRTGVVRDIRIMVYSKVMSLPLGFFSEERKG
DIIARMSGDVGEVENSITSSLDMLIKNPILIVMYFGTLIITSWQLTLFTL
LVVPGMGWIMGKVGKKLKRQSLEAQAKWSDTMSQLEETLGGLRIIKAFIA
EQKMINRFTECSNEFRDATNRVAMRQALAHPMSEFLGTLLIVVVLWFGGS
LILGNHSSIDAPTFIFYMVILYSVINPLKEFSKAGYNIPKGLASMERVDK
ILKAENKIVEIPNPKPLNGLEEQVEFKDISFSYDGKKEVLQHINLTVPKG
KTVALVGQSGSGKSTLVDLLPRYHDVQEGTITIDGVNIKDVRISDLRSLI
GNVNQEAILFNDTFFNNIAFGVENATMEQVIEAAKIANAHDFIMEKEDGY
HTNIGDRGSKLSGGQRQRISIARAILKNPPILILDEATSALDTESERLVQ
EALERLMKTRTTIAIAHRLSTIKNADEICVLYEGEIVERGKHEELLAKNG
YYKRLNDMQSL
>BF2530 putative membrane protein
MLPCGKSKLKDNLIMQHSPIPRVIQREWQRMTSRRLYFGVCLVLPLFTLF
FMATIFGNGQMENIPIGIVDRDNTATSRDITRRMSAVPTFRVTRHFVDEA
EARKAVQQKEIYGYLSIPPRFEQDMISGQDATLNYYYHYALLSVGGELMA
AFESSLAPVALSPIVMKAVALGVNEQQIETFLLPVQANNHPIYNPSLDYS
VYLSQPFFFVLFQVLVLLITVYAVGSEIKFGTAGQWLQAAGGDITVAVTG
KLLPYTLIFSLIGILGNFVMFGILHIPFQGSWLLLNVMTVLFIIATQALA
LFIFSLFPAVAIIISIVSMVGSLGATLSGVTFPVLNMYPLVRDASYLFPV
RHYTEITQTMLYYGGGFIHLWPSAVILCIFPLLALAMLPHLRRAIISRKY
ENIR
>BF3063 putative ABC transport system, ATP-binding protein
MSAIIECKNLTHYYGQRKIYENLSFEVPQGRILGLLGKNGTGKTTTINIL
SGYLQPHSGECRIFGENIQTMDPALRRNIGLLLEGHVQYQFMNITQIEKF
YASFYPGQWKKEAYYDLMNKLKVAPGQRISRMSNGQRSQVALGLILAQNP
ELLILDDFSLGLDPGYRRLFVDYLRDYARSENKTVFLTSHIIQDMERLID
DCIIMDYGSILIQQPIETLMKGLRKYTCTVPEGYQPQLPVTCYHPAVIRQ
TLETYSFLPPSDVEGLLKENQVPFTGLQHENVGLEDAFIGLTGKY
>BF2979 putative ABC transport system, membrane protein
MAHGDHLKYSGKPKAGKKTFLRLISYVACDRRLLIVIGVLIVISIAANLT
GSYMLRPIINDYILPGDFQGLVRILLFLAAIYLTGVAATYIEYILLNKIG
QRTVTRMREELFGKMERLPVRYFDTHQHGDVMSRYTNDIDRISDALTDSL
SDMLSSALTVIGIFCLMIFISPILTAVTLITVPLMFLSAKGIVKRSRKYF
KAQQEALGMMNGYAEEMISGQKVVKVFGHEQKVETDFGILNQSLKDKSLK
AQFYSGLMMPVMQNLNTLNYVIITIVGALLAIFRGFDVGGLAAFLQYSRQ
FGRPINELASLYNSIQAAIAGAERIFEIIDEAPEKADVPEAVTLKNIKGD
VALKNVYFGYRPEKTILKGVSLHAPAGKKIALVGATGAGKTTILNLLPRF
FDIQSGEITIDNHPIDRIERNSLRRSMAIVLQDTHLFTGTVRENIRFGRL
SATDDEVVAAARLTAAHSFIKRLPQGYDTLLENDGANLSQGQRQLLNIAR
AAVADPAILLLDEATSNIDTRSEILIQRGLDQLMQGRTSLIIAHRLSTIR
NADTILVLEHGEIIEQGSHQELLALKGKYYSLNEEQFK
>BF3562 putative exported protein
MKLKNLIACFFLGFIMVSCIQDEAPNAEADIETCTVPGDVLNRDPIIGND
QITLPLKKGTNISKLAPEFTLTPGATINPESGVVRDFSTPQKYVVTSEDG
KWKKEYEVTALFSGIPTSYHFENALPVKDKKGNILYYNFQESDAIGNILN
WANANEGFNYTGVQAKPEEYPTSPAPDGVQGNCVKLTTKDTGSLGALLKM
YIAAGNLFMGSFTLDIGNVLRATKFGVPFTHIPTSFKGYYKYKAGEVFTV
KGEPVSGRKDICDIYAVFYETDDKVKSLDGTNVFTSPNLISIARISNAKE
TEQWTEFNLPFITLPGKTVDSQKLEDGKYNVAIVFSSSIKGDLFEGAAGS
TLYIDEVELSYRDIK
>BF2005 hypothetical protein
MKAKNSEKIIRGYLEFAGGLLISTALSMALLTGFIHTNGSEYKLMESKTQ
EYDKIYARQIALVDKVDSLYNYLVLMGSNDRLNQVVLQKVISTRKMELIE
ELQIMDSKDVLLYKKLASQINVFLDTKEAIRKAVIEESLVRKDLMRCIQD
NKQATRKLTLGNISVEK
>BF2456 putative membrane protein
MIQHYFKIACRNLLKHKVQNILSIVGLSIGFTAFLLGGYWHYWEYHFDSF
HPQSSRTYALTTTGIFKTADGSVGELNQIHQMVEKDLVTFPEIAKVCHVS
EVKYEFEKDTKSWIGMKIDSTFFDIFQCKLIEGSYYKVPFNVNHVILTQK
MANFYFGDSSCVGKELKINDKLSYTIAGVMENYPQNSDFKFEYLILATPS
PNQVKRNTTYVWLHPSADAAHLSKKIAAYRVKEPDTKWSKYSEWHFHLRP
LPEIHTRCSPELKGRLQHIRILATAGILAFASALMNLLVLFIGQQQRKAR
YNATFSTLGASIYSLIGKNLLELTLPLFIAFLLSMAFIEFLFPFYKDYTS
LVAESSSYYNGVIQSITRQEVLKASYWIYPLCCLIFLVLSTVPIVGLLKR
NSRGTSLALRNGLIIGQIFIGSLFLLTSCMFYSQYRFMSRTDKGLVTDHI
WQIDLGFDATYNTDCTPFIEALKQNSAIDDVTALTQPLLVLRGEWYCSFI
TQFPIEGRNNVDEATEDNCIVVQKNFLSFFGMKMKEGEWIQDQGTRDIVI
NETGARELNIPSLTGRLILSDDEDSENHAVPTRISGILRDFYYCPMQYPL
SKVFFMYQNNADAARGYNGFRYFYIKVHPDNEKQALQYARRIYSQYSKKE
ISEDMQIIQLSTLMELFNRPEKTMFRIFLLLAVLCILISSFGVFFLVSLS
TEQRKKEIAIRKVNGAQFSDILYLFLKEYLWLTLVSNAIALPLGYLFIKR
WLETYAYHTDIHGWLFVCVFLFTCIIVILSVMRQVVVAAKINPAESVKSE
>BF3126 conserved hypothetical protein
MPLKLTTYYQGSEIPDFPGTNTFHSKELFQIYEETPGYTPLLIMASEDGK
PVARLLAAIRKSIRMFPPAFIKRCEIYGTGEYLTAEADKERIFGEMLEHL
TTEALRNSFLIEFRNLENAMFGYKYFRSNRYFPVNWLRVRNSLHGIENAE
QRFSPSRIRQIKKGLKNGAKVDEARTVEEIREFSNMLRHLYSSRIRKHFP
NIIFFQHMDTRLIHSRQAKIFIVRYKDKIIGGSACIYSGNDAYLWFSGGM
RKTYALQYPGILAVWKALQDAHQNGFRHMEFMDAGLPFKKHGYRDFVLRF
GGKQSSTRRWFRFRWQWLNDLLIKIYV
>BF1431 putative permease component of ABC transporter
MITIYLKQSYNLLKENRFVNGISIAGTALSVAAVMLIYLVYQVNFSAYAP
ESNRYRILFVSSLQACGSDGHPINNGGMSHKVVRECLYPLQTPEAVTAFT
SGDLPVNVHGQQFYDKYAIKFTDDGFWKVFDFTFLAGGPFTHTDWESGIR
KAVISDKLARRLFGTVEAVGQTLRMNYADYRICGVVKEVSRAAESSYGDV
WIPYTANASLLKDNISYCEGTTGEFQACILSRSRSDFEAIRREMLKLQST
FNASLTGTKLDYMHSPFTQWQAVLGTNGFSEGTVGEWLKSTGAVILFLLL
LPALNIIGITLTQFRKRRSEIGVRKAFGACSFSLVEQVVIENLLTSCMGG
LIGLLLSFGLLSLCKSLFFSGDVSLTHDMLIQPLTFVAAFFFTLILNLLS
AAIPAWRASRMPITEALHDVE
>BF2701 putative membrane protein
MDAANTSNPSDKKKFIWLVILLIIAIVVAVVWWWNYRKYVSTIDANLDGS
RVNVSVRAMAPLSAVFKQEGDSVKRGELLAVLDSTMTEDYRIVSPVDGLI
AKQWVVPGDLLQPGENIFTLNEGKKLWVTVYLQETKFDEVRMGQQALFTL
DAYPGLTFYGKIFYIGANTASEFSLIPPDNASGNYTKVAQRIPLKISIDR
VEGKEKLKANLRLLSGMSANVKIVKE
>BF1933 putative permease component of ABC transporter
MNGTNLFKIALRALNNNKLRAFLTMLGIIIGVASVITMLAIGQGSKKSIQ
AQISEMGSNMIMIHPGADMRGGVRQDPSAMQTLKLTDYETLRDETSFLAA
VSPNVSSSGQLIAGNNNYPSSVNGVGTEYLEIRQLSIDNGEMFSEADIQS
SAKVCVIGKTIVDNLFPDGEDPVGRIVRFSKIPFRVVGVLKSKGYNSMGM
DQDDIVLAPYTTVMKRLLAQTYLQGIYASALSEDMTDNATEEITELLRRN
HKLKEADDDDFTIRSQQELSSMLNSTTDLMTTLLACIAGISLVVGGIGIM
NIMYVSVTERTREIGLRMSVGARGVDILSQFLIEAILISITGGLIGVIIG
CGASWVVKSVAHWPIFIQPWSVFLSFAVCTVTGVFFGWYPAKKAADLDPI
EAIRYE
>BF1252 conserved hypothetical protein
MAEIKNIIASLGLNEKNGLFFVEDSHWKTKTSFPNRVKRLIEYKIKPKAF
FCFDNKPLLLFFENPSNKEKLYEAIWNFNESPIAIIIENNCVEIYNGFNF
LKNEKALEKLGGIDKLNNFSYFELVTGKTWEQYAEPLNYKNRVDYYLLQN
IDAARKILLYEQKLDSKIANALIGKVIFVRYLIDRKVKLCFEGISKYWTN
EEFCILLNDPKKTKDFFDYLENSETGFNGDLFPLRDEEYIQIQPIHYSTI
RRLLKGEDLDEMQPSLFEFYDFSIIPIEFISNVYELFIGKDNQEKEGAYY
TPLFLVDYILKETIENKLNTQDGYECKVLDPACGSGIFLVETLRKIIEKY
IASGVDVKSTEFKNEIKEITKRNIFGIDKDLNAVQVAIFSIYLTLLDYLD
PPAIAEFKFPCLINENFFESDFFNEETEFNILFKDIKFDFIVGNPPWKGG
GIGDLGSKYLKNRKKREKELSKKFDIAINNNEIAEGFVFRVSDFCSDKTQ
VALIIRSSSLYNLGYNKKHNSPFRQYWLEEFFIDRVFELAPVRHEVFEKS
NDPAIAPAAILFYRYAKGVNTNNNIVNHITLKQSRFFSLFKIFTINRSDY
KSVRQQKFKEFDWLWKVLVYGSYLDFNFLKRLTDEHNLIKDIISDESKFI
EGTGIQYSSNPLYDSTHLIGCPFIDSYGVNSFFIDPSKISPFERSKVHRL
RDERLFKSPMLLIREGIDLQKLTAKCTISKQDILFKDSITSIKILNVRDI
DAIYNIAAILSSSLFAYYAINTFVSIGIERERAKNYNKYNLPYIDLNIKN
RIEVIEQAYQERYSAKKEVLQDDKKINALNNTILSELNKINKVIYDKLQL
NDIETALIEYALDINKTFIIGNDEEKARLFLPLKYDDIILNEYVSLFIQQ
FKSKLNDENRVFIAEIWYTKQIIGVFFKMIPIQDYKQDIVWVNKQNNTEL
LSFISKIGTEKITDKLFVQKDIRGFASNGNDFFIIKPNEKRLWYKAIGYM
DVNEFSDAIIKIGRSF
>BF2626 putative transpor-related membrane protein
MTTKYTYKEIWIIAYPILISLIMEQLIGMTDTAFLGRVGEVELGASAIAG
VYYLAIFMMAFGFSIGAQILIARRNGEQQYQAIGPIFYQGVYFLLSLAVV
AFTLSLCFSPHILKKVISSEHIYDASISYINWRVFGFFFSFVGVMFRAFF
VGTTQTKTLTLNSVVMVLSNVVFNYILIFGKFGAPQLGIAGAAIGSSLAE
MVSVIFFVIYTWKRIDCKKYALNHLPGFRPEMLKRILNVSFWTMIQNFFS
LSTWFMFFLFVEHLGERALAITNIIRNVSGIPFMVTMAFAATCGSLVSNL
IGAGEIKCVPGTIRQHIRIGYIFVLPLVILFALFPNLILSIYTDIPDLRE
ASIPSLWVLCSAYLILVPANVYFQAVSGTGNTRTALGLELCVLAIYLIYI
TYMILYLRVDVAVCWTTEHLYGICILFLSYLYIKKGNWQKKQI
>BF1433 putative ABC transporter permease component
MIKLYLKQSWMLIRQNKLFSSLYVLGTGLAIAMTMIIAIVYYIKIAPIYP
EVNRSLTMRMKGVSAMHVKGGGNSYSCSYEMLKDWFYPLQSAELVTAVNE
HFLTRKGSYIQPAGGGEQIPALVKYTDPNFFRLFEFEFLDGKPFSEADLA
SGIRNVVLSDRMARRIFGRTDVVGQTFKQDFKESKVVGVVREGSYLLPAS
YGQIYMPYSCLPGYDKNNDGSHKVGTYVVYFKVRQKEDMPKLYAEVNELV
RKYNTSQKEYTVDIFHQPDPYWQTWFREGNTNEIDWASVIKLYGGALLAL
LLVPAINLSGMISSRMDDRLAEMGIRKAFGANRKQLLNQVLWENLLLTCI
GGLMGLIVSWGLLVLGRNWVFSLFDKYPTVISDGVDVAINPQMLFSPLMF
CVTFAFCLILNLLSAWWPTWRSLHKDIIDSLNEKK
>BF2649 putative ABC transport system, membrane protein
MKQFIAFVKKEFFHIFRDRRTMLILLGMPVVQIILFGFAITTEVKNVRVG
VLDPSNDIVTRKIIDRLDASEYFSVKCLLHSPQEMERAFQENEIDMALVF
SEQFADRLYTGDARVQVVSDATDPNMATTQAGYATGVIAAVRQEMLPPGM
SVPSVVPNVKLLYNPQMKSAYNFVPGVMGLILMLICAMMTSISIVREKET
GTMEILLVSPVKPLFIILAKAVPYFVLSFVNLTTILLLSVYVLDVPVAGS
LFWLIMVSLLFIFVSLSLGLLISTVTRTQVAAMLASGLVLMMPTMLLSGM
IFPIESMPLVLQLISDILPACWYIQAVRKLMIEGVDISFVWSEVSILALM
AVLLITISFKKFKNRL
>BF2213 putative ABC transport system, ATP-binding protein
MIMIEINDISKVFRTSEVETVALNHVSLNVEEGEFVAIMGPSGCGKSTLL
NILGLLDNPTEGSYKLIGQEVADLHEKERTRVRKGKLGFVFQSFNLIDEL
NVYENVELPLTYLNIKASERRRMVDNILHRMNISHRAKHFPQQLSGGQQQ
RVAIARAVVTNPKLILADEPTGNLDSKNGAEVMNLLTELNREGTTIIMVT
HSQHDASFAHRTIHLFDGSIVASVKA
>BF2978 putative ABC transport system, ATP-binding protein
MKKYWQILKKYQISLLACPLLVLVSVMCETVQPMYMADIIDNGVMQRDLS
VITAVGGKMILISIVGLIFSIANVYVSSHASIGFGTDLRTGLFGKIQQLS
FFDIDRFSTASLITRLTSDISRIQQVIMMSMRLMLRSPLMLVMAVFFVVR
INLELAGVLLAAIPILGFSVFFILRKGFPFFLKVQQKVDQLNEVVRENLI
NIRVVKSFVREDFEAHKFKDKSESLRDTVIHASNIIVSIFPVMQLVMNLS
IIAILWMGGHKVMTGELKVGELISFVNYLGQVLMSLMMLSMIIMSYARAS
ASSKRILEVLDTQPSLTDTPEGMRSTREIEKGEIAFEKVSFRYGGGETDV
LRNISFHIRPGETVAIAGATGSAKSSLVQLIPRLYDVSAGEIRIDGIPVQ
DYNLRELHARIGMVLQKNELFTGTIAENLRWGKPDATQEELEVAARAAEA
HEFICSLPAGYDTLLGRGGINLSGGQKQRICIARALLRKPKILILDDSTS
AVDSETELRIRNNLNAWLRDTTVLIITQRIYTMQSANRVILLDDGEIESI
GTPEELLERSEMYQEIYYSQQIVI
>BF3062 putative membrane protein
MIQAIFYKEWIKTRWYLLLATLFMIGITGYSMLRIGRTIAIQGIDHLWVV
MVQKDAIFIDLLQFVPLLTGILLAAVQFFPEMQRKCLKLTLHLPYSQKKM
VMAMLAFGVLALFTCFATSFIIMGVYLPQHFTSELVQRILLSAAPWFLAG
FAGYLLVSWICLEPTWKRRVLNLIIAALIFRVYFLAPGAEAYNSFLPCLT
LYTLLIASLSWISVVRFKAGKQD
>BF1443 putative ABC transport system ATP-binding protein
MITLTSLSKIYRTNEIETVALENVNLTVDRGEFLSIMGPSGCGKSTLLNI
MGLLDAPTTGTIEINGTHTEGMKDKELAAFRNKTLGFVFQSFHLINSLNV
LDNVELPLLYRRVSSSERRKLAQEVLEKVGLSHRMRHFPTQLSGGQCQRV
AIARAIIGNPEIILADEPTGNLDSKMGAEVMELLHRLNKEDGRTIVMVTH
NEEQAKQTSRTIRFFDGRQVQ
>BF3368 putative copper/silver resistance-related transport membrane protein
MINKIIRYFLENRVITILLLTLVVVWGISTAPFNWHGGIVPRNPIPVDAI
PDIGDNQQIVATEWMGRSPKDIQDQITYPLTTSLLGIPGVKTIRSSSMFG
MSFIYIIFEDDIEFYWSRSRILEKLNSLPPGTLPENVQPTLGPDATALGQ
IYWYTLEGRDPKTGKPAGGWNAEELRTIQDFYVKYSLSAAEGVSEVASAG
GFIKEYQIELNPDAMYSFNVSVMDVMNAVKKSNLDIGAETMEVNKVEYLI
RGLGYVKNVADIENTVVTVREGVPVRISDIAFVNIGPGTRRGGLDKEGVE
AVGGVVIARYGSNPLEVINNVKEKIHEMDAGMPQKTLADGTVSKVTVVPF
YDRTGLIKETIGTLETSLSHEILICIIVIIVLVLNLRASVVIASMLPIAV
LATFILMRYTGIEANIVALSGIAIAIGVMVDVGVVFVESIIRYMEMPENK
GITRGKPFVGLIYKAVSEVSGAIATAMITTIVSFLPVFAMQAQEGKMFSP
LAYTKTYALASAFVLGLILLPTLAYILFSVRIDSRLIRRVMNCVLIAAGI
VLFAVYDSVPALGLTAVGINNLLAYRWKNPKTGNYVNIGIALLVAVFYLS
EEWLPMGPQRGLSVNVLFVAGCVAIILALLWILVIFYERILRWCLANRWK
FMMIPAATVVCGFLIWRSIGQEFMPSLNEGSFLLMPTSMPHTGIEQNLDY
VEKLDKRLAAIPEVETAIGKWGRVNSALDPAPVQMFENTINYRPEYIIGE
DGKRARFRVNYDGAFLLKGGGTYNPANGFRLIPADSLVPDSRGDYFRQWR
PEIKNANDIWQQIVNVTHLPGLTSAPKLQPIEARLVMLSTGMRAPMGVKV
YGPTLEDIEQGGKAIEQALKSVPSVIPSSVFYDRAVGAPYLEIKLNRESM
ARYGVAVGDLQEVLSAAVGGMALTRTVEGRERFPIRLRYARELRDSPEAL
SMLLVPTATGIQVPLKELADIEYSRGAQMIQSENTFLVGYVIFDKLSGRA
EVDVVKEASNLLEAKVKSGELVLPKGVSYKFAGNYEQQQRATDRLMIVVP
LALLIVLLVLYFQFRTVTASLIHFSGVFVAFAGGFILLWLYGQPWFMNFS
IAGENMRDLFQMHPINLSVAVWVGFIALFGVATDDGVLMGTYIHHVFLER
DPRTKYDIREAVVEAGLKRVRPAAMTTATTLIALLPVLTSTGKGADIMVP
MAIPTFGGMLIQSMTMFVVPVLQCWWRETVERRREKKNGSEVSEPVTGSP
GI
>BF1057 putative restriction enzyme of type III restriction-modification system
MKLKFKHQKFQEDAAKAVCDVFGGQPYKTFDYQVETRKKDGQTSFEKFTG
FRNHPIVPQLTDEIVLKHIRDIQRAQQIKPSEALEGKYNLTIEMETGVGK
TYTYIKTIFELNKRYGWCKFIIVVPSVAIREGVHKSLEIMKEHFASDYST
PLSYFIYDSKQLGELNAFVTDSKIHVMIINSQKFNATNKDARRIYMKLDD
FGGNCPIDVIAQMNPILIIDEPQSVEGVKTKEGLKRFNPLFTLRYSATHR
ELYNLVYRLDAMEAYNLQLVKKIAVKGISISGTTATEGFVYLEGLNLYPD
KNPTANIGFEVKRTKAVNQVVRALKINDDLYAKSNHLEEYRNDYVITDIN
GVEDSVTFRNGIKLYAGDVAGSVNETQLRRIQIRETILSHIEKEQELFEK
DIKVLSLFFIDEVAKYRRYNPDGKGEYAEIFEQEYTDIIKHLDLSLFNQP
EYIDYLKSTVASKAHEGYFSKDKKGKLIDSKTERGTKESADEDAYDLIMK
NKERLLDRKEPIRFIFSHSALREGWDNPNVFQICTLKQSSAEVRKRQEVG
RGLRLCVNGQGDRMDANVLGEEVHRVNLLTVIASESYESFAKGLQTEMAE
AIADRPQKVTIQLFKDQSLRLANGETIIATEDIAQSIYDSLLENKYIKKG
ELTDKFYEDRKQGEVIFDDELTDYKASIMTILASIYNPREMQPNDARKSK
INLRLSKDKLENSKLQELLKLLCSKSTYTVKFDEKELVERAIESLNEKLR
VSQLYLSVITGQMEKIKSKAALISGEAFKVDANQAHYEKIDAMANDQVKY
DLLGKLTDATNLTRQAVAQILSRIKPNVFGQFKNNPEDFIIKASELINEE
KACLIVKHIEYTPIDQYYDVSVFTRATIQGRLGVNTIKADKHLYDHVRFD
SQNEKTFMERLEENDEIEAYVKLPGNFYIPTPMGKYHPDWAIVFKQKLSK
YPYFIAETKASDSSLQDRRIEEAKIECAKKHFAKTNGGKLKYNKVSSFED
LLKIVTQESV
>BF2098 putative transporter permease protein
MINHYFKVALRLIKRSFLFSSIHILGFVWGMAAAFLIYLWVIDEFTFEDH
NPDAGRIFRVIEANCSESGEVTENPYTSKLLADAFRKEFPQVEEATYLGN
VDMTSLRSGDKFLSLNWMRVDTAFFDVFHFPVVEGDPGRLKSGFNHIVLS
ETLAKKFFGNEPAVGKEVMYNRGMDGESVLRIVGVVKVPRKSHIQFDAIV
GQSFFDKIDVNIVRMSSPWDVRDAMVYVKMRPGTSVSDSDRVRMSRILSK
HTLTERLLRFQPLRDIHLKTDFADISVKNHGSMASIYLFIILAVLIIFMG
AFNFTTLSTARAALRYKEIGVRKVTGAKRKTLIVQFLSESLVQAFISLIL
ALALTELLLPVFNRIMDKDITLQASWSVLVYVVLGIIGVGCLSGSYPAFY
LSAVNPLIAFKGGQKNGKKGGLIRGLLCVQFVIAITLLLCTGIVFKQLNY
LQNKDLGLEKENVVSIYTGLWYNVDGFKQEILKNPNVRSVSMGAEITDYL
EGDKSQGDVLRWTDERGETDSLRMMCIWADGDFVNTFGLKLLKGEGLKAD
GGAYFSGTYDFPVIINEAARKAMKVADPIGMEISGGFGVGTNKKRIVGVV
QDFNFQSLRQKIKPAYLMYSPECLGNIHIKIAPEHKQETLNFIQKKFEEM
APFFIKEFKYKFFSDALNRNYEQERQQSRMLLAFTILAVVIAMMGVFGLV
TLSTRQRTKEIGIRKVNGAHSGGIVKMFCLEYLKWVGIAFVPACPLGYLF
MYHWLDEFAYRTTMSWWLFLGGGLIIAGITLLTVIGQTWRTASQNPVRSL
RYE
>BF2132 putative cation efflux protein
MGTGKGKTDYLLSLIREGKQMTLGQQLRLTAYLSVPAIMAQISSIAMQYI
DASMVGSLGANVAASIGLVSTTTWLFWELCAAAATGFSVQVAHKIGAGDF
VGARKILRQSIAATLVFSSLLVAVGISISGMLPGWLGGDEVIRSDSSLYF
WIFALFLPALQLNFLAGGMLRCSGNMRVPCMLNVLMCLLDIVFNFFLIFP
SRQVEWFGVTFTTPGAGLGVEGAILGTVLAELITAGGMMWYLCRRSPMLR
LSGERGSFLPRKETLSKAFRISLPMGFEHMAICGAQIATTVIVAPLGIIA
IAANSFAITAESLCYMPGYGISEAATTLVGQSLGANRIRLLRRFANITVW
SGMLIMGVMGTLMYMAAPQIIGVMTPVEEIRTLGIEILRIEAFAEPMFAA
SIVAYGIFVGVGNTFVPSLMNFGSIWGVRLTLAAWLAPTMGLRGVWFAMC
IELCFRGVIFLARLWGSNWIYKLRINR
>BF2171 putative transport-related membrane protein
MVNKKKEGLSRLFEIAGQKKSLLLLAGLLSAGSAVCMLIPYWAIYRILYE
LLNHSRELSSIDETNMIRWGWIAFGGLIGGLLLLYASLMSSHVAAYRILY
GLRVRLTEHIGRLPLGYLNGTSTGAIKKTMEQNVEKIENFIAHTIPDLVN
VMATVVVMFLIFFSLDGWLAGVCLAVIVLSIFLQFSNFMGKKAREFTRIY
YNAQEQMSASAVQYVRGMPVVKIFGQSVRSFRQFNAEIEAYKTYALKVCD
TYESGMTYFTVLLNSIVTFILPVGILLMQNDSRSLTLAAVWLFFIILGPG
VASPVYKLMYLGSSTREINEGVSRIDRILENQPVSEPACPKIPATYDIEF
RHVSFSYENKEQATRTEALHDLCFTAPQGKITAFVGPSGSGKSTVANLIP
RFWDVEQGEILIGNVNVKDIATEQLMDLVSFVFQDTFLFYDTLYENIAVG
SSKATRDTVIAAARAAQCHEFIEKLPDGYETRIGDKGVFLSGGEAQRVCV
ARAILKNAPILVLDEATAFADPENEYKMQQALKSLIKDKTVIIIAHRLSS
IVSSDRIIVLKDGRAVQCGRHEELSSQEGVYKKMWNAYTSAFRWQLNVKQ
EKE
>BF3601 putative cation transport related membrane protein
MTGQKTPTALGTEKIGKLLMQYAIPAIIAMTASSLYNMVDSIFIGHGVGP
MAISGLALTFPLMNLAAAFGSLVGVGAATLVSVKLGQKDYDTAQRVLGNV
LVLNIIIGLAFTILTLIFLDPILYFFGGSDETVGYARDYMKVILYGNVIT
HLYLGLNAVLRSAGHPQKAMYATIATVVINTILDPLFIYGFGWGIQGAAI
ATILAQVISLMWQFRLFSNKEELLHFHRGIFRLKRKIVFDSLAIGMAPFL
MNLASCFIVILINQGLKKYGGDLAIGAFGIVNRLVFLFVMIVMGLNQGMQ
PIAGYNFGARLYPRVTRVLKLTIYGATIVTTTGFLMGMLIPGLAVSIFTS
HEELIRQSAEGLRIVVLFFPIVGFQMVTSNFFQSIGMASKAIFLSITRQV
LILIPCLLILPRYFGQTGVWVSMPVSDLIASLISAGMLWWQFRLFRIHGR
QAA
>BF2455 putative ABC transport system, membrane protein
MIRHYLKIACRNLLKYKTQSIISILGLAIGFTCFALAVLWIRYEMTYDTF
HEGFDRIHLVYQKSALSDTGVTTTIPYPVSTSLEKQFPEVEDACGFLFYE
QEVTVDDGAIRQLYEINADSCFMHMFGIQVLSGSLDFLESEERIALTEHA
AKELFGTENPIGKEIKLYGAPKTVCAIVNGWNRHTNLPFSILTGGIRQWH
NAWYHGGFHVFIKLHKEVNAEAFQKKLEQTKLETDSKGGMQNLMVMPISK
CHYTVLADQNAIQFSYILFFSIVGGLVILCSLINYLSLFVSRLRMRSREL
ALRKVCGSSDLHLFTLLVTEYLLILLAAGLMGMALIELVLSPFKELSGVK
EGDIYWESFLYFALVIGCSLATFLPVTFYFNKRTLQSNIQQKTVNRYGYL
GRKISIVFQLSISICFIFCISVIMKQLYYLSTTDIGIERKNIATLSIYPQ
NNLLPAADKIEQFPYVTQVLKGHFSLLPKTASMAMHFKDWDGKQPGDAEI
DMEVLMESEELAQFYGIRLLKGKMLKEGERDAGTIVINEAAAKALGWNDP
IGKKLIRPNGTGTTVIGLVKDFHTTSPTTPIKPIAFIAKGFSGFDLGKGD
VLIKYREGEWPKLKKDIEKLCQKEYPENKIRLSNMEETYDNYLKSEQTLL
KLLSCVAVVCILIAVFGVFSLVTLACEQRRKEIAIRKVNGATLGNILSIF
IKEYLILLLCASFLAFPVSYVIMKAWLENYVEQISIGVSMYVTIFMGIGI
IITACIGWRVWKAARENPAEVVKTE
>BF2477 putative drug resistance transport-related membrane protein
MFSKFFINRPIFATVLALIIVVAGLVTLNILPVAQFPEITPPTVQVSAFY
PGANAETVAQTVGIPIEQQVNGVDGMLYMSSTASSSGAYSLTITFAVGTD
IDMATVQVQNRVNVAQSSLPEPVIVQGVTVQKQSSNIVMFLTMQAQDSVY
DGLYLTNYAQLNLVDQLTRVPGVGAVNVMGAGNYSMRVWLDPEAMRIRNL
SPAQIYQAIQSQNIEVSAGYIGQPIGKNNNNAYQYTLNVQGRLTSPEEFG
NIIIRTEEGGKMLRLKDVARIDLGSSSYNVVSKLKGHPTAAIAIYQQPGS
NSLDVSKGVKAKMQELAQNFPAGVSYNVTLDTTDVINASIDEVLVTFLET
TLLVVLVIFLFLQNWRAVIIPCITIPVSLIGTLAVMAALGFSINTLTLFG
LILAVAIVVDDAIVVVENASRLLETGQYSPKEAVTKAMGEITGPIVGVVL
VLLAVFIPTTLISGISGQLYKQFALTIAASTVLSGINSLTLTPALCALFL
EHNKPSNFFIYKGFNKVYDKTQNLYDRIVKGLLIRPGLALISYGIITAVA
VILFMKWPSTFVPDEDDGYFIAVIQLPPASSLERTQAVGRKVNQILDSYP
EVKDYIGISGFSIMGGGEQSNTGTYFVVLKNWDQRKGKEHTAAAVVERFN
EMAYGIQEAQIFAMVPPAIPGLGASGGLQLQLEDRNNLGPTEMQRAVETL
MATYHTQPALASISSMYQANVPQYFLNIDRDKVQFMGIQLDNVFSTLSYY
MGAAYVNDFVQFGRIYQVKIEAGEQAQKVIDDVLKLSVPNAKGDMVPFSS
FTKVEERLGMDQISRYNMYSTASITCNVASGSSSGEGIQQMEDLIKDQLG
NEFGYEWTSVAYQETQAGNTTTIVFIMALLVAFLVLAAQYESWTSPLSAI
MGLPMALLGAMIGCSVMGTPVSIYTQIGIILLIALSAKNGILIVEFARDF
RAEGNSIRDAAYEAGHVRLRPILMTSFAFVLGVMPLLFATGAGAQSRIAL
GAAVVFGMALNTLLATIYIPNFYELMQKFQENVLDRKKKK
>BF3762 putative transport-related membrane protein
MKDISLKDKITQGINDLFYIWKREFRTTFRDQGVLIFFVLVPLVYPLIYS
FIYTNEVVREVPAVVVDDSRSSLSREYLRKVDATPDIQIVAYCADMEEAK
QMLKDRLAYGIIYIPKDFSSDIAQGKQTQVSIYCDMSGLLYYKSMLLANT
AVSLDMNENIKIARSGNTTDRQDEITAYPIEYEDVAMFNPTNGFAAFLIP
AVLILIIQQTLLLGIGLSAGTARENNRFKDLVPINRHYNGTLRIVLGKGL
SYFMVYALVSVYVLCAVPRMFSLNQIGQPGTLALFILPYLMACIFFAMTA
SIAIRNRETCMLIFVFTSVPLLFISGISWPGAAIPPFWKYFSYIFPSTFG
INGFVRINNMGATLSEIPFEYKALWIQTGFYFLTTCWVYRWQIIKSRKHV
IDKYKEMKNKGKEFFS
>BF2459 putative ABC transport system, ATP-binding protein
MIKTINLQKIFKTEEVETWALNNVSVEVKEGEFVAIMGPSGCGKSTLLNI
LGLLDNPTGGEYYLNGKEVSKYTESQRTNLRKGVIGFVFQSFNLIDELNV
YENIELPLLYMGIPASERKQRVEKAMERMAITHRSKHFPQQLSGGQQQRV
AIARAVVANPKLILADEPTGNLDSKNGKEVMGLLSELNKEGTTIVMVTHS
QHDAGFADRVINLFDGQVVTEVTI
>BF2457 putative membrane protein
MILHYLKIVFRQMAKRKAQTAISILGITAGLLCFSVCNYYNRIFSTGNKD
LATYENQAEICIKERSYQVNIPIEDFEKKIGKDKFEAVAFYVNSSSTITL
DETVYCKVDKTECNADYFKVFPTECIDGSLKQFGISGNEAVVTTEFVKQF
CGGIPPLGKTILNQRGKIHTIIAVIKPYPAGMNNYHSSYDVFLPLPENAS
FGIHKLLLKRPEDAEHISQLLPKLGLFPNHPEWIPQIVLDSQTEHKAGAE
LWVAILGLLVLLVGMINYFSFSIGAFANRYKEISLRNTLGSTYWGLFILL
FLEQAVIILICGIITLAITESLLPWFISTFSNEIQRNLYIDIHRLWVYEC
QYIGGLLLISLLISFISSWHIAHKTIAQGLRGGTTTGQRHIIRNTLLSVQ
LLFSFLFIVGTVGIRMQMKEYDLSANPNLSTEVKKEIMVVNIGRYDRIRE
HQPELINFLRSRRWNAETAYTNRDYSQEYGFTELCFVSDDFFNLMNIKCH
HKPGEPFCYVNEQLYQTLQADSTSESFRFQNQVYPVKGLVHIGPDSPSAK
QLALLPLSAMNDEIGKIYIRLVPDAPRKEVKAEMSKEMNQYLPQNEPFEF
ISLYEEQTGLGAISVMWLFVVCSSICLVITVLGVYGAISIDTIRKQKEVA
IRKINGARLPDIYWLFAKNYLILFLIASVIGGLISLFVMVIGSQHRVILF
DYADPWLWMGPLMLLIGIITATISWQIYYIARTNPAEVIKNE
>BF1461 putative type I restriction enzyme specificity protein
MNGKQLKNSILQWAIQGKLVQQDPNDEPASVLLEHIREEKAKLVKEKKIK
KDKNESIIYRGDDNSYYEKIIATGEVKCIDEEIPFEIPNGWEWERVGNIF
FVTKLAGFEYTKFFTKEAISAFNPIPIVRAQNVRMGFFEENKNEAISEML
SNQLKRSALNKKCLLMTFIGAGIGDTCIFPAERKNHLAPNVAKIEPLDDS
IFLDYAVFALMSPCGQRGVNAIKKSTAQPSLSMETIRKLLIPIPPFKEQK
CISLKLSEVLPLVEKYSKVQKVQNQINDEINILLSKSILQEAIRGKLVPQ
IAEEGTADKLLAEIHKEKERLVKEGKLKKAILTDSVIYKGDDNKYYERVG
KSEIDISDEIPFEIPQSWSWCRLSSVITLLSGRDLTPDRYNSEENGIPYI
TGASNFYNGVSSTLAVSNIRNRTYTNYEVYLIGYGYGKFKEKIHFME
>BF1432 putative ABC transporter permease component
MMIKQIFKMIWNQRRLNGWIWMELLVVFVALWYLVDMFVVQLYSYTRPMG
YDITNCWKLSFDVYPEDADEYVNDTTQTQTEGEALAKILERLRRAPEVDN
ACVAFYSSPYSGGNSWTQIMPCTADSSKFKEQSYHQYIVSAEFYDVFRIK
SREGKPLSELLTQKQLSYFITPALEKDFFGSQSAVGQKVRYPGSTREIHI
AAVTAPVRITEFVKPEPELFFTMWPKELERQVNATGASNMEVTVRMKEEL
TSEQMGHFLNRMKNQLTENNLYITGMEDMKQQRSDRLQYEWRKISINLLL
SVFILLNVLFGITGTFWLRIEQRRCETGLRMALGSTRRRVGWFFTAEGWL
LLTTVVPLVLVVIFNMVHMEIPDLYNLSFTWWRFAVSFGGVLLLMGLIIA
LGTRLPARRAMKLQPAEALHYE
>BF0011 putative ABC transporter ATP-binding protein
MLLHRFPVEYQMDSQDCGPASLKIIAKHFGKFYSLQFMRDRCGITKEGVS
LLDLSTGAESIGLRTLAIKCTIDDVVNSIPFPAIVFWNDSHFIVVYHSDR
KYIWVSDPAKGRIKYTHEEFRKGWYQRDESQGVLLAVEPTTDFKNSKAEQ
EQKRNSFSSILKYFFPYKKSFGLIFIIMLVVTVLQGMLPFISKAVIDVGI
KTSDRNFINMVLIGNICILLSVMIFNVLRDWILLHITARVNIALISDYLI
KLMKLPVTFFENKLLGDILQRAQDHERIRSFIMNNSLALIFSTLTFAVFS
IILLIYNTIIFYIFLSGSVLYACWVLLFLSIRKKLDWEYFELLSKNQSYW
VETVSTIQDIKIYNYDKYRRWKWEEIQARLYHVNKRVLAITNAQNLGAQF
IENIKNMAIVFFCAMAVIKGEITFGIMISTQFIIGMLNGPLVQFINFVVS
AQYAKISFLRINEIRQLENEDELLSIGSTTILPERKTILLENIHFQYTPN
SPLVLRNIYLQIPENKITAIVGGSGSGKSTLLKLLVRLYKPSHGEIKMDK
MNVSAINLRQWRNMCGVVMQDGKIFSDTILNNIVLDDEQINYTRLREVCR
IAQIEDEINAMPKGFETTIGETGRGLSGGQKQRLLIARALYRDPKFLFMD
EATNSLDSINERKIVNALNNAFEQRTVVVIAHRLSTIRNADQIVVLDKGF
IVETGTHEILMEKKGHYFELVSSQVQD
>BF2792 putative transmembrane protein
MSLVNNFTVKKVRSSNLELLRLLSMFFVLVVHADFQALGMPDRTEMTILP
LFSVFRIIIEAFAIVCVNSFVLLSGWFGINFHIKSLCNLLFQCAFFLIGI
YTFTILIGIEPLSISGIKRCLMLTNNVWFVKCYLGMFIMAPILNAFVEKT
DKRTFSTVLLSFFIFQTIYGWFSNGAPYFEKGYSAFSFMGLYLLARYVRI
YQPSYTQWSKSKNLLMYISLSTFTALMLIITCYFDKVGYFCMFWTYTSPL
VIAGALYLLLFFNRFAFQNKGINWIAASCFAVYLFHFFIWEYFMKPHIQQ
LAVTYNGISCLLVITGLLLTFFTAAILIDKIRLYIWNHFVSKYIS
>BF2311 putative type I restriction modification system related protein
MKNNDLTTYGEYLEKLSPKHGREKVFNDFLQIVVCCLSMGRKEELYFKTI
KPYDKTELDLFSQAFAALVMQMDRQPLVDPFGDYFQEFLSNAQNGQFFTP
FGVCELMNQLITAPKVSDQPKQGDRRVLDPACGSGRLLLSAAQKDRALTF
VGIDISYTCCLMTIINLCLNSLNGEVLHMNALTDQYWHRWLIIVDSVTKI
PTVYEVEAGIINQPPACADDLKPLPVTGIIQPVKNMIPANFVRYTPKC
>BF3349 putative multidrug resistance/siderophore transport related, membrane protein
MNLRTFIERPVLSAVISITIVVVGIIGLFTLPVEQYPDIAPPTIMVSTSY
FGASAETLQKSVIAPLEEAINGVEDMTYMTSSATNAGTVSITVYFKQGTD
PDMAAVNVQNRVSKATGQLPSEVNQVGVTTSKRQTSILQMFSLHSPDDSY
DEAFLANYISINLKPEILRISGVGDMMIMGGDYSLRIWMKPDVMAQYRLI
PSDVSTVLAEQNIESATGSFGENSDETYQYTMKYKGRRITPEEFGEIVIR
STDDGQVLKLKDIATIELGQESYAYSGTTDGHNGVSCMLFQTAGSNATEV
NNQINRFLEEARKELPQGVELTQLMSSNDFLYASIHEVVKTLLEAILLVI
LVVYVFLQDIRSTLIPLVGIIVSLIGTFAFMAIAGFSINLITLFALVLVI
GTVVDDAIVVVEAVQARFDVGYKSSYMASVDAMKGISNAVITSSLVFMAV
FIPVSFMSGTSGTFYTQFGLTMAVAVGISAVNALTLSPALCALLLKPYIN
EDGTQKQNFAARFRKAFNAAFDVVVEKYKGIVLFFIKRRWLTGSLLIASI
ALLVVLMNTTKTSLVPDEDQGVIFVNVSTAAGSSLRTTDDVMKRIEERME
QIPQVKHVQKVAGYGLLAGQGSSFGMLILKLKPWDERPGKEDDVQAVIGQ
VYGRTADIKDASVFAISPGMIPGYGMGNALELHMQDKTGGDVNEFFQTTQ
QYLGALNQRPEIAMAYSTFDVRYPQWLVEVDPSKCKRAGITPDQVLSTLS
GYYGGQYVSNFNRFSKVYKVMIQSDPQYRLDEASLNNTFVRMSNGEMAPL
SQFLTLTRTYGAESLSRFNMYNSIAVNAMPADGYSTGDAIRAVQETASTS
LPKGYGYDYGGITREENQQSGTTAIIFGICFLMIYLILSALYESFLIPFA
VLLSVPCGLMGSFLFARMFGLENNIYLQTGLIMLIGLLAKTAILLTEYAA
ERRKAGMGLIASALSAAKARLRPILMTALTMIFGLLPLMVASGVGANGNR
SLGTGAVGGMVIGTLALLFIVPSLFIAFQWLQERIRPVQIEPSHDWQIQT
EQEVSEHEKEEAKNRPLK
>BF3055 putative antiporter membrane protein
MYTNKQIWSVSYPILLSLLAQNVINVTDTAFLGRVSEIALGASAMGGLFY
ICIFTIAFGFSTGSQIVIARRNGEARYGDVGPVMIQGVLFLLVMALLLFG
FTKAFGGNIMRLLVSSESIYDATMEFLDWRIFGFFFSFVNVMFRALYIGI
TRTKVLTINAVVMALTNVVLDYALIFGHFGLPEMGIKGAAIASVIAEAAS
LLFFLIYTYITVNLKKYGLNRLRSFDPVLLMRILSISCFTMLQYFLSMAT
WFVFFVAVERLGQRELAIANIVRSIYIVMLIPVNALATTTNSLVSNAIGA
GGINYVMPLINKIGRFSFLIMLGLVIITALFPQALLSVYTNETALINESV
SSVYVICVAMLIASVANVVFNGISGTGNTQAALMLEAITIAIYGSYIIFI
GMWVKAPIEWCFTIEILYYTLLLATSYIYFKKAKWQNKKI
>BF4315 putative transmembrane AcrB/D/F-family transporter
MKLVKYFLQKRAVTILLLVLVLAGGLFSYFKMGKLEDAPFTIKQALVLTS
YPGASPAEVQSQVTDILEEAIQSLGELYYLKTENRAGLSKITVYVKKEIR
AEEMQQLWDKLRRKVNDVQDKLPAGAGTSIVNDDFGDVLGVFYGLTGDGH
TYRELEDQAKFIKNELLKVKDVAKIEIYGVQTPTIDVLISPSVMAQSGVT
TADIMRAFEAQNKMVDAGGIDAGTNRIRIESTGNFYSLDDIRDLTIVSRT
GEHFRLADIAQIEEGYQTPPANQMRINGSPAVGIAISTVPTGNVVDMAEN
VKMRIGELSQSMPDGYELISIYDQGYESAVANQGFILNLIISVITVVAIL
LFFIGFKNGLLIGSGLVFSIFATLIVMMACDIALQRMSLAAIIIAMGMLV
DNAIVVSDSALINMERGMRKRVAIMRACSSTALPLLAATVIAILTFLPIY
YSPHITGELLSSLVVVIGVSLMFSWVFALTQTPFFIQEFVRRPRPEELKA
SLFDGKYYHLFRKSLRWVLRHRTMTIASLVVLLLLSAWSFKFIPKVFVPA
LDKQYFTVDMWLPEGTTIGETDRIAGEISDYIRTHEETEMVSSYIGRTPP
RYYLSNISFGPQSNYAQLLVKCKSSKESRALNALLQDSIRLKYPEPLIKV
NKFELSPLTEAMIEARFLGPDPAVLDSLAGEAIEIMRRNPKVADARNEWG
NMSMVMRPVYDPVKAGALGITKSQMMESVKSISDGTRVGVYRDDEKKVPV
LLKSEGADITDARSLGNFSVWNGEHSAPLSQVTERIETTWEWPQMRTYNR
QLSMAAMCGVKSGYTMAEVHGEIRKEIEAMKVPEGYTFFWDSQYKDQREA
MEAIGKFFPLAFLVLVVILVALFGNFRDPVIILCVLPLSIIGVAVGMLLT
GFDFGFFPIAGWLGLLGMVIKNVIVLLDEIDVQRREGVVPYTAVIESTVS
RTRPVLMAATTTILGMVPLLFDIAFGGMAATIIFGLTFATLLTLFVTPAL
YAIFYKIKEK
>BF0800 putative transmembrane protein
MGSKKTDLMRISYFVAIVILVCLIGNLKDLWLQSWTDLIIYLIVLFAAAE
CLFSTFARIRAVGEQKQPRWLTSISLLIYGILFLGTLFFIGDFLINKL
>BF2453 putative conserved membrane protein
MKTIRLAWKALARFRTYTFINILGLALSLACVLIILRYIHQEVTVNHFCK
DLENTYLLYIEYEDGRRTISSNEDRNNDPNFIDPLNDPSVLKSTRWINFP
EDRITVGKQIYNVKTVVTDSVFLQILPYPSVSGISSLKSPNDAIITRRLA
ERLFGKENPIGKTMTYSTGDIVTVTGVIGEPTTKSFLDFDLIISERLQHS
WSRLSNSLVQLIPGTDFKKLNVKNEKFMKLRCHMDAPTRLQFFPLKDFYF
DKTVRVYNNNIRKGNYNNILVLAVVTIALLIIGLFNFINIYTVMMLKRAR
EFGVKKVYGAGAKDVFAQIFTENFILTGMALCISWCIIEITGGMMEHVLR
IPQTSNTEFSATLSVGILILLPLLTSIYPFIRYNYVSPSVSIRSVNAGGH
SIVSRVLFLFVQYIITFVLIIVSLFFTKQVRFMLSADLNYTTKDIIQCQL
YAERSSYDINISYEEWERRKQREKSNLAYIKEEMDHSPLFIRWEYGENPN
QLDDNYINVRNAQRDEFKQVIYSSLSNKYIELFGFQLKEGRLWNDSVDQW
TDYKMIINESAKSLLEIDNIETALIQPERRLWWSLSKSEEMKKNPPYQVI
GVIKDFKIGHLSKTTPPLFIVYEDPRGSYRDRLMAQIVPGKKQEAIAFLK
RLRDEILGEGEFEYSFLEDEIATMYQEDKRTAEIYSLFSIIAILISCLGL
FGLSMFDIRQRYREIALRKVNGATLKEIYPLLLKKYSIILGMAFIISAPL
SWYIISKYLEGFANKAPISWWLFAIAAIVTAFISLATLIWQIRKAANINP
AKVLKGE
>BF0068 putative undecaprenol kinase
MEWFEALILGLIQGLTEYLPVSSSGHLAIGSALFGIEGEENLAFTIVVHV
ATVFSTLVILWKEIDWIFRGLFKFEMNSETRYVINILISMIPIGIVGVFF
KDEVEAIFGSGLLIVGCMLLLTAALLSFSYYAKPRQKENISMKDAFIIGL
AQACAVLPGLSRSGSTIATGLLLGDNKAKLAQFSFLMVIPPILGEALLDG
MKMIKGEAIAGDIPTLSLIVGFIAAFVSGCLACKWMINIVKKGKLIYFAI
YCAIVGVVTIVVSQLQ
>BF3962 putative transmembrane Acr-type transport protein
MSLYEGAVKKPIMTSLCFLAVVIFGLFSLSKLPIDLYPDIDTNTIMVMTA
YPGASASDIENNVTRPLENTLNAVSNLKHITSRSSENMSLITLEFEYGND
IDVLTNDVRDKLDMVSSQLPDDVENPIIFKFSTDMIPIVLLSVQANESQS
ALYKILDDRVVNPLARIPGVGTVSISGAPQREIQVYCDPGKLEAYNLTIE
TISSIIGAENKNIPGGNFDIGNETYSLRVEGEFDDSRQLEDVVVGSYNGA
NVYLRDVARVVDTVEERAQETYNNGVKGAMIVVQKQSGANSVDISKKVAE
ALPKLQKNLPSDVKLGVIVDTSDNILNTIDSLAETVLYALLFVVIVVFLF
LGRWRATLIICITIPLSLIASFIYLAVTGNTINIISLSSLSIAIGMVVDD
AIVVLENVTTHIERGSDPKQAAVHGTNEVAISVIASTLTMIAVFFPLTMV
SGMSGVMFKQLGWMMCAIMFISTVAALSLTPMLCSQLLRLQKKQSKTFKL
LFGPIEKGLDALDTGYARMLNWAVRHRPIVIFGCIVFFVVSLFCAKSIGT
EFFPAQDNARIAVQLELPIGTRKELAQEVSEKLTNQWLNKYKGVMTVCNY
TVGQADSDNTWASMQDNGSHIISFNISLVDPGDRDISLEQVCDEMREDLK
KYPEFSKAQVILGGSNTGMSAQASADFEVYGYSMEETDSVAARLKRELLN
VKGVSEVNISRSDYQPEYQVDFDREKLALHGLNLATAGNYLRNRINGAIA
SKYREDGDEYDIKVRYAPEYRTSIESIENILIYNSRGEAVRVKELGKVVE
RFAPPTIERKDRERIVTVSAVISGEALGNVVNAGNAIIDKMDIPSNVTIQ
VAGSYEDQQDSFRDLGTLAILIVVLVFIVMAAQFESLTYPFIIMFSLPFA
FSGVLMALFFTKSTLSVMSLLGAIMLIGIVVKNGIVLIDYITLCRERGLA
VLNSVVTAGKSRLRPVLMTTATTVLGMIPMAIGGGQGSEMWSPMAIAVIG
GLTVSTILTLVLIPTLYCVFAGTGIKHQRKVLRRKRELEAYFEEHKDEMI
KK
>BF2210 putative ABC transport system, membrane protein
MRQLYYTFRTLLRGRGINLTKIISLTLGLLVGILLFARVAFELSFDGHYK
EVDRLCVINAVYYVGGEKGEAHQVVLAPVPGAIAEGFPDEIESSTVVRIR
YGDNTLFYNNVRQCPKMILSDSLFFKTMGIDIISGDPRELVNPETMFVSR
SFARRIFGDESPIGKTLLYNRTLPMTIKGVYEDIPENSSLYHEVVISFST
IEKHHWECMGWECGDSFQGYIRLKNASDLDKVNSRIDPIIEKHLPFRPEE
GFAIRYSLQPIRGVHASAPVIQKMVMIMSLLGLVILFIAAMNYVLISISS
LARRAKAIGVHKCNGASERNIFSMFLWETGIIIMISLILVGVLVLNFRED
IEYLASASIGALFTWETLWVPICVIVILFIVAGIIPGHLFSSIPVTHVFR
NYTERKGGWKRTLLFLQFTGVTFVLGILCVVLLQYNRITTKPIGYNPEGI
AFTYHNFADSESALDNLRRLPMVSDVSDSESSIISGYGGLAVTDENGIIL
FTTRLNACLYNYVPFMGIRIKEGRNLNGPDQALVNEEFVRQMRWTDGAVG
KKYENFTIVGVMENFPVNSYYEEQDPVAFIGQQQINNCYHVRLKQPYEEN
LRSLNKSMEEMYPTEDIVFKSLSYSIEDQYQNVRRFRDAVMLAFVVILLI
SLMGLIGYISDEIQRRSKEIAIRKVNGAEVSHILNLLSKDIIWTASPAVL
FGTAGAYFVGIQWLGQFAERISLQVYWFVLIAIVVLAMIFLSAVIKVWHI
ANENPVKSIKSE
>BF1079 putative type I restriction enzyme
MNTIPLVDSERTTQNRVVNLLHDYCGYQYLGYKQDADNLPIIPEILGKFI
KDTQHASNTEIDKVFRLLDLEISRCHDKDTLFQSNLNFYSYLRYGVNIQG
DDGQSKTVKIIKWSEDNVADNIFSLAEEVTVRRNIEEYHTRRPDIVVYVN
GMALGVIELKKSTVSVKDGVRQQIRNNGRDNEICHFFVPAQFLFAGNDSE
GVHYGTILTPEKFWLRWKEPTGQSYPNDTSTPEPIPELFPRTEFPNELDR
SLLQMLEPKRILRLIHDCVVYDGGIKKVCRPNQYFAFEAAKPRIRNKQSG
IIWHSQGAGKSLMMVWLAQWILENMPNDPRVVIITDRDELDKQIENGFKD
AGHKPIRAKSGNHLLSMLSEVEPNLICTLIHKFGIAGQEESAFSAEEKKL
RGKRSPEQYMAALAEKLPKGFKAKGNIFVFVDECHRTQGGILNKAMKKIM
GDDVMLIGFTGTPLLKQQKSKLTSRENFGNYIHTYKFNEAVKDQVILDLR
YEAREIEQNLENEQAVDQLFEHITRNLSSKAKEELKSRWAVMKNLFSSRD
RVRKIVADIVKDMQLISCLREGWGNAMLVCDSIYQAYRCWEVFQETQLKG
HCAVVSSFNGKDASPEESSSGETQSEAEYKAEMAKKMFKDRTPEEFEEWA
KTQFVDHPGDMKLLIVVSKLLTGFDAPSATYLYLDKKMEGHDLFQAICRV
NRTNNEYEEKEFGYIVDYKQLFKNIEDAVNDYTTGAFSDYDKEDVEGLLT
DRFENAKRDLDTALERVEHLCEPVAHPKTTNEFFDYFVFDQRSTEPNEEE
AATIQSAPIREAFYNAVKILVTRYSAIALEMERAGYTTEEAQTIFERIKN
FDNIRNAIMRRAGDIVDMKLYDQQMRNILDMYIDAKSSKVLAMLEDFSFL
DLVLDSNSEEAEHEAEEALGGKDGVASTITANVRRVVNRKRESNPEEYRK
FSERINRLLAEYRQGVLDYKEYLKAIAELARELGNRTFDPRLDTQGKQAL
FDNLGEDVALTLEVYQLIKVNAKQGFRTNDVKKAKLRRALESFTASKPFD
VDDILRIVINNPEF
>BF2946 acrD, putative aminoglycoside efflux pump
MKVSFFIDRPVFSIVISILIVIIGIIGLTMLPVDQYPQITPPVVKISASY
PGASALTVSQAVATPIEQEINGTPGMLYMESNSSNSGGFSATVTFDVSAD
PDLAAVEIQNRVKLAESRLPAEVIQNGISVEKQAPSQLMTLTLMSSDPKF
DEIYLSNFATINVLDVIRRIPGVGRVSNIGSRYYAMQIWAEPDKLANFGL
TVQDLQNALKDQNRESAAGVLGQQPVKGLDVTIPITTQGRLSTVEQFENI
VIRANTNGSIIRLRDVARVSLEASSYSTESGINGKNAAVLGIYMLPGANA
MEVAKSVKEAMDEISKNFPEGLSYEVPFDMTTYISESIHEVYKTLFEALI
LVVLVVYLSLQSWRATLIPIVAVPISLIGTFGFMLIFGFSLNILTLLGLI
LAIGIVVDDAIVVVENVERIMEEEKLPPYEATKKAMNGLAGALIATSLVL
CAVFVPVSFLSGITGQLYRQFTITIAVSVLISTVVALTLSPVMCSLILKP
DNGKKKNIVFRKINHWLNVGNHKYVIAIRRVIGNPRRVLAGFGVVLIGIL
LIHRLIPTSFLPVEDQGYFKIELELPEGATLERTREVTDRAITYLEKNPY
IAYVQNVTGSSPRVGSNQARSELTVILKPWEDRKDTSIDEIMSNVRHDLS
EYPECKVYLSTPPVIPGLGTSGGFEMQLEARGEATFENLVQAADTLMYYA
SQRKELTGLSSSLQSDIPQLYFDVDRDKVKMLGVPLADVFSTMKAYTGSV
YVNDFNMFNRIYKVYIQAEAPYREHKDNINLFFVKASNGAMIPLTSLGNA
SYTTGPGSIKRFNMFTTAVFRGEAAQGYSSGQAMEIMEQIARYHLPDNIG
LEWSGLSYQEKKAGGQTGLVLALVFLFVFLFLAAQYESWTVPIAVLLSLP
VAALGAYLGVWVCGLENDVYFQIGLVMLVGLAAKNAILIVEFAKVQVDRG
GDLIQSAIHAAQLRFRPILMTSLAFVLGMLPMVLATGPGSASRAAIGTGV
FFGMIFAIVVGIILVPFFFVLVYKTKAKLKNVPNVNVKLPFKSKKKTD
>BF1262 bexA, putative transmembrane MatE family multidrug efflux transporter
MNMNITYISIYKTSLPVLVSLLMEYLIGFTDTAYLGRVGETELAASAIAG
TYYMIIYMIGFGFSIGAQILIAQYNGNQQYKEAGKILSQGILFLLIIAVI
VILFSSIISPIILKSIIDSESVLQAVLQYLDWRIYGFFFSFTIIMFRAFY
IGIIHTSALMLNSITMVAINVILNYILIFGALGIPVLGISGAAIASVISE
AVAVIHFIIYTQKNVSSCKYGLKRRITIDCTILKKILSISIWMMLQHGLV
FGSWFVFFITMEHFGERSLAITNIVRNISSFLFLFVQAFASVVSSLVGNL
IGENKGNSILYVCKKVIFLCYMTILPIMVLFLFFPSSTLRIYSDNTVLVF
EAIPTLKVMLTSYLIAVPTFVFFSAVSGIGHAVASLLIAFISLVVYIVYV
ETISHFSSSVPLLWTSEHIYFSCVFILSLYHIHHSWMSFINQDKKLTTNI
S
>BF1199 cepA, beta-lactamase
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDG
QDTITVNNDIHYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKP
DTYSPLRETYPQGGIEMSIADLLKYTLQQSDNNACDILFNYQGGPDAVNK
YLHSLGIRECAVIHTENDMHENLEFCYQNWTTPLAAAKLLEIFRNENLFD
KEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGDRNAKGQQIGC
NDIGFILLPDGHVYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>BF0627 dinF, putative DNA-damage-inducible protein F
MNKQMHISNGNKRILQIAVPSIISNITVPLLGLVDVTIVGHLGSAAYIGA
IAVGGMLFNIIYWIFGFLRMGTSGMTSQAFGQRNLEEVTKLLLRSVGVGL
FIALCLMTLQYPIQKAAFAFIQTSDEVERLATLYFRICIWGAPAMLGLYG
FAGWFIGMQNSRFPMYIAITQNIVNILASLCFVFLFGMKVEGVALGTLIA
QYAGFLMALLLWLRYYKQLRKRVHWRGIWQKQAMYRFFQVNRDIFLRTLC
LVAVTMFFTSAGAAQGEVVLAVNTLLMQLFTLFSYIMDGFAYAGEALAGR
YIGAGNRMELHRTVRQLFGWGVGLSAGFTLLYGIGGQSFLGLLTNESSVI
QEADTYFYWVLAIPLAGFSAFLWDGIFIGATATRQMLFSMFIASASFFLT
YYIFQEVMGNHALWMAFIIYLSLRGLVQAFLAKKIVH
>BF1838 hsdM, putative type I restriction enzyme methylase
MSEEQQRILKAQLWKMACEMRGNMNASDFMNFGLGLIFYKYLSERIEMFI
NDQLQNDNTDFRTVWADGNEDIKQELRNVAIEDIGYFLEPEYLFSTLATD
AKDGKFILEALGQSFKHIEDSTLSADSEDDFQNLFDDVDLTSVKLGKTAD
DKNKLISNLLLALDEIDFCLKDTEIDILGDAYEYMIGEFAAGAGQKAGEF
YTPQQVSKVLAQIVTADKERVRNVYDPTCGSGSLLLSVAKEGFAEFIYGQ
EKNPTTYNLARMNMLLHNKRYDKFDIRSGDTLEDDQFENEVFDAIVANPP
FSAQWSADSKFNTDDRFSRAGALAPKSKADYAFILHMIHHLHDGGTMACV
APHGVLFRGASEGKIRRYLIEAKNYIDAIIGLPANLFYGTSIPTCILVLK
KCRKEGDDVLFIDASKGFEKIKTQNKLSPEHIEKIVNTYKNRAEIEKYSH
KATIEEIAENDFNLNIPRYVDTFEEEEEIDIKAVMKEIKMLEAKRSELDR
QIDVYLKELGLVF
>BF1836 hsdR, putative type I restriction enzyme R protein
MTIQSEQALEQGLIKTLVSMNYQKIEIADENALIVNFRNQLNIHNNIELT
DDEFNRIMIHLDSGSIFVKAEKLRNRFPLTRDDESVKWIEFLNTQEWCKN
EFQVSNQITDEGRRKCRYDVTILVNGLPLVQVELKKRGVELKQAYSQVQR
YHKTAFKGLFNYIQIFVISNGVNTRYFANNPNQGYKFTFPWADFKNNHID
RLDLFAAMFFEQCTLGKMLAKYVVLHQSDKCLMILRPYQFYAVEALLDKV
ANSVKNGYIWHTTGSGKTLTSFKAAQLIAEMSDIDKVLFVVDRHDLDTQT
KKEYDAFAPGAVDSTDNTKELVKALQGKKKLMITTIQKLNNAVQKDRYSK
GLQGVKDKNIVMIFDECHRSQFGEMHSNITGFFSKIRYFGFTGTPIFADN
ANNGCTTKDIFGERLHEYLIKDAIADENVLGFLVEYHGKWKRKSENDKQV
KSIDTAEVLLKDERIASITDFILSNYNSSTYERDFNAMLAVGGVKMLIKY
YDMFKSRNHDLKIATIFTYTQNEESEDEFTGLGQGFVSVQNTRDILESYI
KDYNETFGTEFDTDHFGLYYDDINKRMKNRQIDLLIVSDMFLTGFDAKKL
NTLYVDKNLNYHGLLQAFSRTNRVLNEKKKFGKITCFRDLKQQTDDAIKL
YSNNKSSEVVLMKPYEKLVERFNEMAAEFLSYFPTVKSVGNLESELDKRR
FVILFRAMLRLRNEVKGYNEFDAEDLTIEEQRFADYQSKYLDMSNEFAIT
SEKEDAESILQDIDFELELVHRDIINVMYILALLQDLKPESSSYPKDRKA
VLDTMDSNPELRSKIALIDNFIKLHIDGRQSNDLPADMESDLDKYIATQK
AIAIEQVATEEGIDSTLLHEYISEYEYLGKPKNEIIKRAIDPLKLSFMDA
QSKKKSLIDKMKDIIKLFSWN